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  The fluorescence of the intracellular electron donor reduced nicotinamide adenine 
dinucleotide (NADH) is a well established probe of cellular metabolic state. This 
technique, called redox fluorimetry, can be combined with two-photon microscopy to 
provide functional imaging deep in living neural tissue with a spatio-temporal resolution 
far exceeding that of conventional functional imaging techniques (e.g. fMRI, PET). This 
resolution offers a new opportunity to explore spatio-temporal heterogeneities in the 
response of neural tissue to stressors such as metabolic inhibition and activity induced 
metabolic load. These metabolic responses were found to differ between cell types in the 
brain (astrocytes and neurons) and between sub-cellular compartments (mitochondria and 
cytosol). The time course of compartmental responses revealed that transient hypoxia 
caused an NADH increase followed by a post-hypoxic mitochondrial NADH 
hyperoxidation and a cytosolic lactate accumulation. A similar analysis of the time course 
of electrical activity induced metabolic responses revealed that the metabolic cost of 
neural activity was first met by oxidative neuronal metabolism followed by glycolytic 
metabolism in astrocytes. 
  The accuracy of redox-fluorimetry is limited however, by the effect of the local 
environment on the fluorescence of intracellular NADH. To characterize the effect of the 
intracellular environment on the photophysical properties of intracellular NADH, we 
measure its time resolved fluorescence and rotational anisotropy decays. These decays 
characterize the excited state and rotational dynamics of intracellular NADH, and from 
them we can infer how metabolic inhibition affects the enzyme binding states of NADH 
and the local viscosity for NADH rotational motion. The net effect is a reduction of the average lifetime of intracellular NADH fluorescence upon metabolic inhibition, causing 
the fluorescence increase during inhibition to underestimate significantly the actual 
concentration increase.  
  Historically, measurements of the NADH response to metabolic perturbations 
have not significantly described the complexity of this response. The research presented 
here shows that metabolism associated changes of intracellular NADH are not only 
spatio-temporally heterogeneous, but also entail changes in the NADH conformation and 
its photophysical properties. By characterizing and accounting for these effects, we make 
progress towards quantitative redox-fluorimetry and the development of an accurate 
picture of in vivo NADH dynamics.  
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Chapter One 
Introduction 
 
 
1.1 Biological context and motivation 
  Metabolism in the central nervous system (CNS) remains an area of active 
research and profound controversy (1). This controversy surrounds every scale of 
neural systems – from sub-cellular and cellular metabolic compartments to functional 
regions in the brain. At the smallest scale – the distribution of metabolic load between 
aerobic and anaerobic processes remains controversial (2,3). The role of astrocytes and 
neurons in supplying energy for rapid electrical activity and whether the demand is 
dominated by pre-synaptic of post-synaptic processes (4) is also uncertain. There is 
even evidence that chronic inhibition of mitochondrial metabolism is linked to 
neurodegenerative diseases (5). 
The wealth of open questions in the field of neurometabolism requires 
techniques that can monitor rapid changes in metabolic processes on a cellular and 
sub-cellular level. Current techniques to probe neural energy metabolism are limited 
by either temporal or spatial resolution. Metabolic mapping techniques have revealed 
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the distribution and/or activities of metabolic enzymes on regional, cellular and sub-
cellular scales in the brain. However these techniques, which include 2-deoxyglucose 
autoradiography (6,7) and cytochrome oxidase histochemistry (8) require fixation and 
staining of tissue, making them ill suited for the study of rapid metabolic dynamics in 
living systems.  
In contrast, in situ techniques such as positron emission tomography (PET) and 
functional magnetic resonance imaging (fMRI) are routinely used in measuring neuro-
metabolic and neuro-vascular dynamics in living subjects. PET utilizes 
18F-
fluorodeoxyglucose as a tracer to image glucose metabolism in the intact brain (9). 
Functional magnetic resonance imaging utilizes changes in the blood oxygen content 
as an indirect measure of neuronal activity (10). However the spatial resolution of 
these techniques (>>1mm), possibly to the level of single cortical columns, while 
adequate to discriminate macroscopic anatomical regions in the brain, is insufficient to 
resolve metabolic processes on a cellular level. Two-photon microscopy (2PM) (11) 
provides an ideal technique for high-resolution fluorescence imaging in highly 
scattering tissue such as brain (12,13).  
Reduced nicotinamide adenine dinucleotide (NADH) - a fluorophore intrinsic 
to most tissues - is also the principal carrier of reducing equivalents in energy 
metabolism. NADH and its non-fluorescent oxididized form NAD
+ form a redox pair 
(Fig.(1.1)) whose population ratio ([NADH]/[NAD
+]), as measured by intrinsic 
NADH fluorescence, is a well established probe of metabolic state in systems ranging 
from cultured cells to intact tissue (14,15). This technique, known as redox-
fluorimetry, has traditionally used UV light to excite NADH fluorescence. Due to the 
low penetration of UV light into tissue, fluorescence is excited from essentially only 
the surface of the tissue. Combining redox-fluorimetry with 2PM however provides   3
the opportunity to monitor metabolic dynamics, with high resolution, deep in 
functioning neural tissue.  
 
Fluorescent Non-fluorescent
Nicotinamide Nicotinamide
NAD+ + H+ + 2e- NADH
Fluorescent Non-fluorescent
Nicotinamide Nicotinamide
NAD+ + H+ + 2e- NADH
Fluorescent Non-fluorescent
Nicotinamide Nicotinamide
NAD+ + H+ + 2e- NADH
 
Figure 1.1 NADH and NAD+ form a redox pair. NAD has two nucleotide rings – 
adenine and nicotinamide. The nicotinamide ring is fluorescent in NADH but not in 
NAD
+. 
 
1.2 Towards quantitative redox-fluorimetry 
Numerous theoretical treatments of cellular and mitochondrial metabolism 
have been developed (16-20) to elucidate the relationship between NADH 
concentration and other metabolic parameters such as rate of oxygen consumption, 
levels of ATP and other intermediate metabolites. The synthesis of these theoretical 
treatments with experimental measurements from redox-fluorimetry aims to develop a 
complete picture of in vivo cellular metabolism.  
To achieve this synthesis however, we must be able to measure the in vivo 
concentration of NADH rather than just the fluorescence. Quantifying in vivo NADH 
concentration dynamics involves characterizing the effect of a number of factors   4
which can broadly be categorized as physiological factors, molecular factors and 
 
optical factors (Fig. 1.2).  
hysiological Factors:
Figure 1.2 Current state of redox fluorimetry 
P  Intracellular NADH fluorescence and its response to 
metabolic stressors (e.g. metabolic load, inhibition, etc.) have been well characterized 
in many systems. However, until recently, redox-fluorimetric techniques have lacked 
the spatio-temporal resolution to explore the heterogeneity of this fluorescence and its 
dynamics in the brain. Combining the high resolution of 2PM of intrinsic NADH with 
motion correction algorithms, we are able to follow differences in the neurometabolic 
dynamics of cellular and sub-cellular compartments. Motion corrected two-photon 
redox fluorimetry of neurometabolism is developed in Chapters 3 and 4.  
Molecular Factors: The fluorescence observed in 2PM depends on not just the 
fluorophore concentration (C) but also on the photophysical properties of the 
fluorophore itself, specifically its 2P absorption cross-section (σ2) and fluorescence   5
quantum yield (Φf) (21). The quantum yield of NADH is known to be affected by its 
local environment and isomerization state. As a result, inferring intracellular NADH 
concentration from its fluorescence requires a characterization of the intracellular 
NADH conformation and local environment, presented here in Chapter 5. A 
consideration of the two-photon absorption cross-section of intracellular NADH will 
not be presented as, to date, no good method exists to measure σ2 in tissue. 
Optical Factors: Both the excitation and emission light is attenuated due to 
wavele
tension of conventional redox-
fluorim
ngth dependent scattering and absorption in brain tissue – considerable work 
has been done on characterizing these effects by other researchers, and hence their 
results will be summarized only briefly in Chapter 5.  
    The work presented here represents an ex
etry. By furthering the ability to quantify intracellular NADH concentration 
and resolve the fine spatial structure of its dynamics, we come closer to being able to 
quantitatively describe neural energy metabolism in native neural tissue.   6
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Chapter Two 
Background and Experimental 
Procedures 
 
 
2.1 Overview of cellular energy metabolism  
2.1.1 Pathways of NADH oxidation and reduction 
  The pathways of metabolism that are particularly relevant to our studies of 
NADH are those of the respiratory cycle or glucose/energy metabolism (1). Energy 
metabolism can be conveniently considered as four distinct sub-processes which either 
source or sink NADH and whose relative rates therefore determine the cellular 
concentration of NADH. 
  These four pathways, represented schematically in Fig.2.1, are: 
1. Glycolysis (Yield: 2 NADH per molecule glucose) 
Glucose + 2Pi + 2ADP + 2NAD
+  Æ 2Pyruvate + 2ATP + 2NADH + 2H
+ + 2H2O 
          (2.1) 
This is a 10 step process catalyzed by 10 different enzymes. The sole enzyme that uses 
NAD
+ as a substrate is glyceraldehyde 3-phosphate dehydrogenase. The key control 
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enzyme in glycolysis is the allosteric enzyme phosphofructokinase (PFK) (1). The 
activity of PFK – and therefore the forward rate of glycolysis increases in response to 
ADP build up or low levels of ATP.  
  Glycolysis is not an efficient source of ATP however (net yield = 2 ATP), and 
is typically used only as a rapid but brief ATP supply. Glycolysis is a common path 
between anaerobic (non-oxidative) and aerobic (oxidative) metabolism. The end-
product of glycolysis, pyruvate, is either channeled into mitochondria for aerobic 
metabolism or is converted in the cytosol to lactate for anaerobic metabolism. 
 
 
Figure 2.1 Cellular pathways of NADH oxidation and reduction. 
 
2. Lactate Production (Yield: -2 NADH per molecule glucose) 
Pyruvate + NADH + H
+ Æ L-Lactate + NAD
+     (2.2)   10
Lactate production together with glycolysis represents anaerobic respiration. This 
occurs when oxygen levels are low enough to impair the rate of the mitochondrial 
electron transport chain. This reaction is catalyzed by lactate dehydrogenase. 
  Various techniques have demonstrated that the cytosolic [NADH]/[NAD
+] 
ratio is in equilibrium with the cytosolic and extracellular [lactate]/[pyruvate] ratio (2-
4). Thus changes in the cytosolic NADH fluorescence reflect changes in the 
intracellular [lactate]/[pyruvate] ratio. 
 
3. Pyruvate Dehydrogenase - Citric Acid Cycle (Kreb’s Cycle) (Yield: 4 NADH per 
molecule glucose) 
Pyruvate + CoA + NAD
+ Æ acetyl CoA + CO2 + NADH      (2.3) 
Acetyl CoA + 3NAD
+ + FAD + GDP + Pi + 2H2O Æ  
2CO2 + 3NADH + FADH2 + GTP + 2H
+ + CoA 
This oxidative decarboxylation of pyruvate is a critical step in metabolism. While 
pyruvate can be used by the cell for a number of other processes – once it has been 
converted into acetyl CoA, the only use for it is in the Citric Acid Cycle (Kreb’s 
Cycle) and hence the cell is committed to aerobic respiration. The Kreb’s cycle is the 
principle source of NADH in mitochondria. Kreb’s cycle enzyme activities are 
regulated by effectors such as calcium (Ca
2+) influx during activity as a means of 
regulating mitochondrial metabolism (see Section (2.1.2)).   
  
4. Oxidative Phosphorylation: The Electron Chain (ETC) and ATP Synthase (Yield: -2 
NADH per molecule glucose) 
2NADH + O2 + 2H
+ Æ 2H2O + 2NAD
+  ∆G
0 = -105.2 kcal/mol  (2.4) 
ADP + Pi + H
+ Æ ATP + H2O  ∆G
0 = 7.3 kcal/mol   11
The electron transport chain is a sequence of 4 enzyme complexes embedded in the 
mitochondrial inner membrane that transport a pair of electrons from NADH to O2. 
The free energy liberated in this reaction is used by three of these enzyme complexes 
to pump protons out of the mitochondrial matrix into the cytosol. 
  The active transport of protons leads to the creation of a chemical and 
electrical gradient across the mitchondrial membrane and therefore to the creation of a 
chemical potential: 
  2.3 FR T p H µ ∆ =∆ Ψ − ⋅ ∆  (2.5) 
Where  ∆Ψ and ∆pH are the differences in electrical potential and pH across the 
membrane. Hence the free energy of NADH oxidation is transferred into the chemical 
potential of the electro-chemical gradient across the mitchondrial membrane. This free 
energy is then used to create ATP – by coupling the activity of ATP synthase to the 
flow of H
+ ions back into the mitchondrial matrix. 
 
2.1.2 Mitochondrial NADH level 
  Much of the work presented here will entail perturbing mitochondrial 
metabolism and monitoring the resulting change in NADH fluorescence. It is therefore 
useful to develop a qualitative, intuitive picture of the factors affecting mitochondrial 
NADH levels. This immediate discussion is not intended to be quantitative, as 
quantification will be introduced throughout the text as it becomes possible. The 
simple picture of mitochondrial metabolism is schematically depicted in Figure (2.2).  
  The NADH level in the mitochondrial matrix is determined by the balance of 
two reactions: the reduction NAD
+ to NADH in the Kreb’s cycle and the oxidation of 
NADH to NAD
+ by the electron transport chain. 
•  vK = kK[NAD
+] is the rate of reduction of NAD
+ to NADH by the Kreb’s 
cycle. The rate constant kK is actually a collective term that is a function of the   12
activities and substrate levels of several of the Kreb’s cycle enzymes (e.g. 
isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, malate 
dehydrogenase). We define it only to separate the effect of the NAD
+ 
concentration from all other factors on the forward velocity of the Kreb’s 
cycle. The ‘rate constant’ is only a constant for a given metabolic state – 
metabolic perturbations effect substrate levels and enzyme activities, thereby 
altering the value of this parameter.  
•  vE =kE[NADH] is the rate of oxidation of NADH by the electron transport 
chain (ETC). The rate constant kE is again a complex function of ETC enzyme 
activities, substrate levels, mitochondrial membrane potential, etc. 
Figure 2.2 Regulation of mitochondrial [NADH]/[NAD
+] level 
 
  In essence, the rate constants kE and kK represent the ‘conductance’ of their 
respective chemical pathways. To follow the analogy, the chemical concentration 
([X]) corresponds to the driving ‘potential’ – and the reaction velocity is therefore the 
‘current’.    13
  The two reactions, i.e. NADH source and sink, are treated here as irreversible 
reactions. This is a simplification made for the purpose of a qualitative understanding 
and is not strictly true. However, the standard free energy change ∆G
0’ for the NADH 
oxidation by the ETC is so highly negative ((Eqn(2.4), -105.2 kcal/mol) (1) that the 
standard equilibrium constant K’eq (from Eqn.(2.4)) is ~ 2x10
77 M
-1. The high negative 
value of ∆G
0’ is indicative of an irreversible reaction – likely receiving the dominant 
contribution to the free energy change from a decrease in entropy. The ∆G
0’ for the net 
reaction of the Kreb’s cycle is not quite so dramatically negative (-9.8 kcal/mol). 
Nonetheless, its K’eq (from Eqn.(2.1)) is still ~1.6x10
7 M
3, indicating that while the 
reaction may be reversible, it is very forward biased and hence it is not a bad 
approximation to take the reaction as irreversible. 
  At a given steady state level of NADH, the source and sink velocities of 
NADH must be equal: vK = vE. 
[] [ KE k NAD k NADH
+ ⇒= ]  
 
[]
[]
K
E
k NADH
NAD k
+ ∴ =  (2.6) 
  Control of respiration by the cell itself or by external pharmacological agents is 
exerted by influencing the rate constants kK and kE. This can be done by modulating 
the activity of a particular enzyme (e.g. with Ca
2+ or CN) or by affecting a substrate 
level (e.g. with hypoxia). It is the change in the rate constants that changes the 
[NADH]/[NAD
+] level. This simplistic model expressed by Eqn.(2.6) can explain the 
effects of various drugs or metabolic processes on the mitochondrial NADH level. 
These effects are summarized in Table 2.1.    
  Cyanide (CN): CN competitively binds to the oxygen binding site on complex 
IV of the electron transport chain(5,6). This can be interpreted as effectively reducing 
the substrate (O2) concentration available to the ETC, or reducing the activity of   14
complex 4 of the ETC. In either case, the rate constant kE is reduced while the Kreb’s 
cycle rate constant is not directly affected. This leads to an increase in 
[NADH]/[NAD
+] by Eqn. (2.6). 
  Hypoxia: Reducing O2 concentration has the same effect as introducing CN, 
i.e. ETC substrate limitation reduces the ETC rate constant kE without a direct affect 
on the Kreb’s cycle(7). This leads to an increase in [NADH]/[NAD
+]. 
  FCCP: FCCP (carbonylcyanide-p-trifluoromethoxyphenyl-hydrazone) is 
known as an uncoupler as it uncouples the oxidation of NADH from the production of 
ATP(8). FCCP is a weak lipophilic acid that transports protons across the 
mitochondrial membrane and thereby collapses its membrane potential. The collapse 
of the membrane potential enhances kE without immediately affecting the Kreb’s 
cycle. This leads to a decrease in [NADH]/[NAD
+]. 
 
Table 2.1 Mechanisms of effectors of mitochondrial NADH   
Effector  kK  kE  [NADH] /[NAD+] 
= kK/kE 
CN 
(inhibition)  Constant  ↓  ↑ 
Hypoxia 
(inhibition)  Constant  ↓  ↑ 
FCCP 
(uncoupling)  Constant  ↑  ↓ 
Ca2+ Influx 
(load) 
↑ Constant  ↑ 
  
  Calcium Influx: Ca
2+ is used by many cell types as a signaling molecule during 
enhanced metabolic load to upregulate mitochondrial activity by enhancing the   15
activity of three dehydrogenases in the Kreb’c cycle (for review, see (9-12). This 
increase in kK with constant kE increases the mitochondrial [NADH]/[NAD
+] (8). The 
elevated mitochondrial NADH then increases flux through the ETC and thereby 
increases ATP production. There has been some evidence recently however that the 
NADH response in neurons responding to elevated activity is not Ca
2+ dependent (13) 
– leaving the precise mechanism of the upregulation of mitochondrial metabolism in 
response to elevated demand somewhat uncertain.     
  Even with a simple model of mitochondrial metabolism, we can already see the 
essential features of the NADH response to effectors emerge. It is noteworthy that 
both uncouplers (e.g. FCCP) and elevated metabolic load (Ca
2+ influx) increase the 
ETC velocity (vE) and therefore the O2 consumption rate. However, they produce 
opposite effects on the NADH level – uncouplers like FCCP reduce [NADH], while 
elevated Ca
2+ causes an increase in [NADH]. This apparent disparity is readily 
explained by the differential effects of these molecules on the Kreb’s cycle and the 
ETC.  
Models of mitochondrial or neuronal metabolism, as have been developed by 
several theorists (7,11,14,15), are complex and take into account the pathways 
associated with glycolysis, lactate dehydrogenase, mitochondrial membrane shuttles, 
the phosphocreatine buffer system, Ca
2+ regulation, NADH-NADPH 
transhydrogenase, etc. However under normal conditions, many of these pathways 
yield only second order effects on the NADH level in cells – and consideration of only 
a relatively small number of NADH influencing pathways (in this case 2) is sufficient 
to gain a qualitative understanding of NADH effectors. 
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2.2 Two-photon fluorescence microscopy 
  Microscopy was done on either an upright or an inverted two-photon 
microscope, both schematically represented in Fig. (2.3). The particular microscope 
was selected based on the application. Inverted microscopes use coverslip corrected 
objectives that have numerical apertures (NA) as high as 1.3. The high NA yields 
better spatial resolution, and excitation and collection efficiencies. However they have 
small working distances (~200µm) and require a coverslip between the objective and 
the sample. These microscopes are well-suited for imaging cell cultures in which cells 
naturally form a thin (<20µm) layer on a coverslip. They can also be used in 
experiments on brain slices where no direct access to the imaging plane is required by 
other hardware such as electrophysiology electrodes. 
 
 
Figure 2.3 Generic two-photon laser scanning microscope   17
  In contrast, upright microscopes use physiology objectives – i.e. objectives 
with large working distances (<3.3mm) designed to be immersed in water with no 
cover slip between the objective and the sample. These objectives compromise NA 
(<1), but due to their large working distance, are ideal for experiments in which 
hardware access is required to the imaging plane (e.g. electrophysiology) or using a 
cover slip is not possible (e.g. in situ brain imaging). More recently – Olympus has 
developed a series of objectives to be used with upright microscopes that have large 
working distances, high NA (0.95) and are available in both a coverslip corrected 
version and a physiology version.    
  For high-resolution imaging of cultured neurons, a Zeiss F-Fluar, 40x NA 1.3, 
oil immersion objective was used. For brain slice imaging on the inverted microscope, 
the Zeiss C-Apochromat 10x NA 0.45 Water and the Olympus U-Apo/340 40x NA 
1.15 Water were used. For slice imaging in the upright microscope, the objectives 
used were either an Olympus LUMPlanFl 40x NA 0.8 water immersion or an 
Olympus 20x 0.95 water immersion. Slice imaging in the small volume, airtight 
chamber required long working distance and cover slip correction - hence a Zeiss C-
Apochromat 10x NA 0.45 Water or an Olympus 20x 0.95 coverslip corrected 
physiology objective were used. 
  The inverted microscope was a Zeiss Axiovert 135TV mounted with a Biorad 
MRC1024 multi-photon imaging system. The upright microscope was an Olympus 
BX50WI mounted with a Biorad MRC600 multi-photon imaging system. A solid state 
pumped Ti:Sapphire pulse laser (Spectra Physics Millenia-Tsunami combination) 
provided the excitation at 737 nm with a pulse-width of ~100 fs and a repetition rate 
of 80 MHz. The 2P-fluorescence was filtered from the excitation beam using a 670 nm 
long pass dichroic mirror (Chroma). Appropriate filters were chosen to detect the 
wavelength range 350-500 nm for the intrinsic fluorescence. The fluorescence was   18
detected by photomultiplier tubes (350-500m: Hamamatsu HC125-02, 510-650nm: 
Hamamatsu HC125-01). Images (512x512 pixels) were typically acquired within ~1 
second.  
 
2.3 Steady State (Wavelength Resolved) Fluorescence Spectroscopy 
2.3.1 Solution steady state fluorescence spectroscopy 
  One-photon excited wavelength resolved steady state spectra of aqueous 
solutions were measured in commercial instruments. The samples were held in 3x3 
mm quartz cells (Starna Cells Inc.). Absorption spectra (2 nm resolution) were 
measured with a single beam diode array spectrophotometer (8451A, Hewlett 
Packard). Fluorescence emission spectra were recorded using a PTI-QM-1 fluorimeter 
(Photon Technology Int.) with 1 nm resolution. NADH (Sigma) samples were 
dissolved in either PBS (pH 7.4) or in HPLC water buffered with Trizma 
Hydrochloride (Sigma) at pH 7.4. Unless otherwise specified, NADH fluorescence 
spectra were measured at 340 nm excitation and excitation spectra were measured at 
460 nm detection.  
To characterize the effect of enzyme binding on NADH fluorescence, NADH 
(10 µm) was titrated with 0-50 µM mitochondrial malate dehydrogenase (mMDH, 
Roche Applied Science) in water buffered with Trizma Hydrochloride (pH 7.0). The 
fluorescence was normalized to the signal from unbound NADH. Assuming a simple 
reversible binding reaction, the dissociation constant (Kd) was calculated from the 
measured NADH fluorescence signal F as a function of mMDH concentration using 
F=(1+Φ[mMDH]/Kd)/(1+[mMDH]/Kd). The factor Φ is the fluorescence 
enhancement upon binding to mMDH. 
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2.3.2 In vivo fluorescence spectroscopy: scanning stage technique 
  Time or wavelength resolved fluorescence spectra of the cellular intrinsic 
fluorescence were acquired on a modified inverted microscope, described in detail 
below (Fig. (2.4)), using a scanning stage technique. In order to maximize 
fluorescence collection efficiency, the excitation beam was maintained stationary with 
respect to the microscope and the sample was scanned using a computer controlled x-y 
stage (SCAN IM, Merzhäuser). This ensured that the collected fluorescence was also 
stationary with respect to the microscope and could therefore be easily coupled to an 
optical fiber (for wavelength resolved spectroscopy) or focused on to a small surface 
area (<1cm
2) fluorescence lifetime detector.    
  The sample stage was scanned in such a way as to effectively raster scan the 
excitation beam in a 100x100 µm square in the stratum radiatum or in a 100x50 µm 
rectangle in the stratum pyramidale. This stage scanning was not done to spatially map 
the fluorescence, but rather, simply to distribute the two-photon excitation dose over 
an area of tissue ~10
4 times larger than the area of the focused beam. This enabled 
long integration times of the collected fluorescence without damaging the tissue. All 
spectra were acquired from 70-100 µm within the slice. 
 
2.3.3 In vivo fluorescence spectroscopy: wavelength resolved spectroscopy 
  Fluorescence was excited in the sample using the scanning stage technique 
described above. The collected fluorescence was coupled to 550 µm multimode fiber 
with high transmission in the UV and visible wavelengths (Oz Optics) and then 
imaged onto the entrance slit of a spectrometer (270M, SPEX) equipped with a liquid 
nitrogen cooled CCD camera. An image of the sample was first recorded and the 
intracellular region of interest was selected. The acquisition of a cellular spectrum 
required a dwell time of about 30 ms/µm
2 using an average excitation power of ~15   20
mW (cultured cells) or ~20 mW (brain slices) measured after the objective at 737 nm. 
This dwell time is substantially greater than the ~1 µs/µm
2 dwell time characteristic of 
laser scanning microscopy, which raises concerns of photodamage to the cells. 
However, no morphological photodamage or fluorescence changes  were observed 
during the acquisition time.  
  The spectral response of both the two-photon microscope and the spectrometer, 
combined, were calibrated using an Oriel Quartz Tungsten Halogen 63358 calibration 
lamp or alternatively by using solutions such as fluorescein or aqueous NADH whose 
emission spectra were measured on the commercial fluorimeter specified above for 
measuring fluorescence in aqueous solutions. The wavelength calibration of the 
system was carried out using lines from a calibration standard mercury lamp (Ocean 
Optics HG-1). 
 
2.4 Time-resolved fluorescence spectroscopy 
2.4.1 Definition of Fluorescence and Anisotropy Decay 
  The fluorescence emitted by a sample is the vector sum of parallel ( () I t & ) and 
perpendicular ( ) polarization components. These orthogonal directions are 
defined with respect to the polarization of the excitation light. In the experiments 
described throughout this work, these two fluorescence components are typically 
measured sequentially, rotating an analyzer before the photo-detector and integrating 
the fluorescence signal for equal times. Having measured these two fluorescence 
decay curves, we can calculate the total fluorescence decay curve ( I
() It ⊥
tot(t), also known 
as the magic angle fluorescence decay) and the rotational anisotropy decay curve 
(r(t)), defined by equations (2.7) and  (2.8) respectively. 
 
  () () 2 () tot I tI t G I t ⊥ = + &  (2.7)   21
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  Here, G, known simply as the G factor, is the degree to which the optical 
detection path preferentially transmits one polarization over the other. The total 
fluorescence decay is a measure of the population of the excited state. The anisotropy 
of the fluorescence is the degree to which molecular orientation polarizes the emitted 
fluorescence. The anisotropy is initially non-zero because the excitation beam 
polarization selectively excites a particular orientation of molecules. The value of the 
initial anisotropy depends on the angle between the excitation and emission dipoles. 
The decay of the anisotropy measures the decay of the net molecular orientation due to 
rotational diffusive motion (see Section (2.4.4)). The characteristic decay time, known 
as the rotational diffusion time, characterizes the timescale of this diffusive motion. 
 
2.4.2 Experimental Set-Up   
  Fluorescence was excited in the sample using the scanning stage technique 
described earlier. The fluorescence decay of NADH in solution or in tissue was 
measured using time-correlated single photon counting on a modified inverted Zeiss 
IM-35 microscope as shown in Fig. (2.4)(16). The 740nm, ~100fs laser pulses (80 
MHz repetition rate) were pulse picked down to 10Mhz with a Pockel Cell (Conoptics, 
Danbury, CT). The beam was then directed through the light-inlet port the microscope. 
A small fraction (~1%) of the beam was split off by a coverslip (CS) and focused onto 
a photodiode (PD) to provide a trigger signal for the time resolved acquisition 
electronics. The epi-fluorescence from the sample was filtered from the excitation 
light using a dichroic mirror (M1) and an emission filter (F). The polarization 
component of the fluorescence was selected using a Glan-Thompson prism (P) 
mounted at the top-exit port of the microscope before being detected using a   22
microchannel plate photomultiplier (MCP) (Hamamatsu MCP-PMT R3809U-50). The 
total fluorescence decay is measured using magic angle (54.7°) polarization, while 
anisotropy measurements entail separately and sequentially measuring the parallel and 
perpendicular component fluorescence decays as described above. 
 
 
Figure 2.4 Two-photon scanning stage spectroscopy apparatus 
 
  Under our experimental conditions, the optical depolarization due to the 
microscope objective (40x, 1.15 NA, with an underfilled back aperture) was negligible 
(17). 
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2.4.3 Functional form of fluorescence decay 
  The total fluorescence decay was calculated from the recorded parallel and 
perpendicular fluorescence decays according to Eqn.(2.7). The total fluorescence 
decay (Itot(t))  was then fit using either the commercial Becker & Hickl SPCImage 2.4 
fitting program, or custom written fitting routines in Matlab. These programs utilize 
non-linear least-squares fitting algorithms to fit the fluorescence decay with the 
functional form: 
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Terms in Fitting Equation: 
1. Decay kinetics: The sum of exponential terms in this expression represents the 
excited state dynamics of the fluorescence. Each individual exponential term 
( exp( / ) i at i τ − ) represents the decay of the excited state via a particular pathway. 
These different pathways can be associated with different fluorophores, different 
conformations of a fluorophore, or simply different excited to ground state transitions 
in a fluorophore. For the purpose of general discussion, we will simply refer to the 
physical sources of these exponential decay components as species, since a more 
precise physical identification is case-specific. The amplitude ( ) of an individual 
decay component is equal to the fractional population of the species associated with it. 
Hence it follows that the sum of the fractional populations must be unity (
i a
1
1
n
i
i
a
=
= ∑ ). 
The lifetime of a decay component is equal to the inverse of the total rate of transition 
from the excited state to the ground state, i.e. 
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Where kr is the radiative rate – the rate of relaxation from the excited to the ground 
state involving the emission of a fluorescence photon - and knr is the total non-
radiative rate, the net rate of transition to the ground state not involving the emission 
of a fluorescence photon. The fluorescence quantum yield is by definition the fraction 
of those transitions back to the ground state which involve emitting a fluorescence 
photon. 
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2. Scattered excitation light: The delta function term ( 0 ( at t 0 ) δ − ) in Eqn.(2.9) 
represents backscattered excitation light. Since the excitation pulse is ~100fs in 
duration, the backscattered light will also be comparable in duration, with some 
temporal stretching due to the variability in pathlength of backscattered photons 
reaching the detector. The duration of this backscattered pulse is far below the 
temporal resolution of our detector (~10ps) and hence we can approximate it with a 
delta function. While this term can be excluded for measurements in solution, it is 
necessary in highly scattering tissue such as brain slices.  
 
3. Amplitudes and Offsets: Ibaseline in Eqn.(2.9) is the baseline or background signal, 
approximated as constant for all times. This background is largely from ambient light 
(e.g. computer monitors), and not from fluorescence. While other fluorophores are 
present in brain tissue, we will show in Section (3.1) that under our excitation and 
emission filtering conditions, only NADH and NADPH are significantly detected. I0 is 
the peak fluorescence at time t0, where t0 is the temporal offset of the fluorescence 
decay from the start of the acquisition window. 
   25
4. Response function: R(t) is the measured temporal response function of the system, 
recorded using second harmonic generation from crystals of KDP* or rat tail collagen. 
This response function is convolved ( ( ) ( ) ( ') ( ') ' f tR t R t f t t d t
∞
−∞
⊗= − ∫ ) with the guess 
fit function and then compared to the observed decay. 
 
Derived Quantities 
Once the total intensity decay fit parameters have been obtained by the fitting 
program, we can calculate a number of useful derived quantities:  
1. The average lifetime <τ> of the fluorescence.   
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2. The fraction of the total fluorescence generated by species ‘i’ is fi.  
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3. The change in the concentration of species ‘i’ upon hypoxia. 
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2.4.4 Functional form of fluorescence anisotropy decay 
  The fluorescence anisotropy decay of a freely rotating molecule in an isotropic 
environment is usually described adequately by a single exponential: 
 
  0 ( ) exp( / ) rt r tθ = −  (2.15)     26
Where θ is the rotational diffusion time of the molecule and r0 is the initial anisotropy. 
The anisotropy decays of many conventional fluorophores (e.g. fluorescein, coumarin) 
as well as NADH in solution or NADH fully bound to malate dehydrogenase in 
solution were found to follow this functional form. The initial anisotropy (r0) is solely 
a property of the fluorophore itself, and is related to the angle between the absorption 
and emission dipoles (δ ) by Eqn.(2.16).  
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Based on the number of photons absorbed (α ), the maximum theoretical  -values are 
0.4 and 0.57 for 1-photon and 2-photon events respectively (corresponding to collinear 
dipoles, without depolarizing processes, i.e.
0 r
0 δ = .  
  The rotational diffusion time on the other hand, depends not only upon the 
fluorophore molecule itself, but also upon environmental conditions. This dependence 
may be summarized by the Stokes-Einstein equation (Eqn.(2.17)).  
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Where Drot is the rotational diffusion coefficient, V is the hydrodynamic volume of the 
molecule, η is the local viscosity of the environment and T is the absolute temperature. 
This relation approximates the hydrodynamic volume (molecule + hydrodynamic 
shell) of the molecule to be spherical, which is a reasonable approximation for NADH 
(18). We use the Stokes-Einstein relation later to estimate the viscosity of the 
intracellular environment. 
  While a single exponential anisotropy decay approximates the decay of a free 
fluorophore, more complicated decays are also possible under certain circumstances.   27
Of particular relevance here, associated anisotropy is the form of fluorescence 
anisotropy arising from a mixture of fluorophore species – each fluorophore species 
having its own distinct fluorescence decay and fluorescence anisotropy decay. The 
fluorescence anisotropy decay from the mixture is the average of the fluorescence 
anisotropy decays of the individual species, weighted by their respective fluorescence 
decays. Fitting the anisotropy decay with the associated anisotropy model associates a 
distinct rotational diffusion time with each lifetime decay component as described by 
Eqn.(2.18) (19,20).  
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Where each species ‘i’ has its own set of total intensity decay parameters (ai, τi) and 
set of anisotropy decay parameters (r0i, θi).  
   
2.4.5 Fitting protocol 
  The analysis of anisotropy decay curves is somewhat more difficult than a 
simple non-linear least squares fit provided by most commercial data analysis 
software. Hence, it was necessary to write custom programs to do these fits. The 
fitting protocol employed during this analysis is a form of global analysis specifically 
modified for analyzing associated anisotropy decays. 
  Recall that the actual measured fluorescence decays are the parallel ( () I t & ) and 
perpendicular ( ) polarization components of the fluorescence decay. From these 
one can calculate the anisotropy decay curve using Eqn.(2.19). 
() It ⊥
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In practice however, we do not actually calculate r(t), but rather we calculate the 
numerator and denominator separately. By convention, the numerator is called the 
difference curve (D(t)) and the denominator is called the sum curve (S(t)), simply 
reflecting the operation between the parallel and perpendicular fluorescence 
components. Both the sum and difference curves are sums of exponentials. 
Furthermore, in practice, the functional form of each is more complicated than a 
simple sum of exponential terms. The most general form of both the sum and 
difference curves is analogous to Eqn(2.9), that is, there are terms to account for 
baseline, scattered light, temporal offset and detector response. 
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To fit these individually with a minimization algorithm, we must define a reduced χ
2 
for both these curves.   29
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Where n is the number of data points in the curve, pS is the number of fitting 
parameters and Sfit is the trial fitting function. An analogous definition can be made 
for the difference curve D(t), but with a slightly different weighting factor. 
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  In order to facilitate the fit, we reduce the number of floating parameters in the 
functional form of the fitting function. Specifically, in Eqns.(2.20) and (2.21), the 
baseline intensities (Ibaseline,S, Ibaseline,D), the peak intensities (I0,S, I0,D) and the temporal 
offset (t0) can be calculated trivially from the curves themselves and set as constants 
while executing the fitting routine.  
  Furthermore, by examining the functional form of the sum and difference 
decays (Eqn.(2.20) and (2.21)) we see that there are a set of parameters that the sum 
and difference curves share in common, namely the amplitudes and time constants of 
the total fluorescence decay, i.e. the (,) ii a τ . Only the parameters characterizing the 
anisotropy decay  0 (,) ii r θ are specific to the difference decay. The parameters that are 
shared between the sum and difference decays are known as global parameters. The 
existence of global parameters enables us to employ a fitting protocol known as global 
analysis (21,22). This technique fits two or more curves simultaneously that have a set 
of shared parameters and sets of parameters identified with individual curves. A   30
measure of global goodness of fit must then be defined, known as the global chi-
squared (Eqn.(2.24)).  
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Where pglobal is the number of global parameters. The fitting protocol is schematically 
represented in Fig.(2.5). 
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Figure 2.5 Anisotropy and lifetime global analysis fitting algorithm. Simultaneous 
fitting of sum and difference curves allows the simultaneous extraction of lifetime and 
anisotropy parameters that. 
  Thus, by performing a global fit, we can simultaneously fit S(t) and D(t) and 
automatically satisfy the constraint that certain shared parameters must have the same   31
values in both fits. The global fit then provides us with both the total intensity decay 
parameters  (,) ii a τ  and the anisotropy decay parameters  0 (,) ii r θ  in a single 
minimization operation with an improved resolution on the shared parameters. 
 
2.4.6 G factor determination 
  The G factor describes the extent to which the detection system is 
preferentially sensitive to one polarization over the other due, e.g, to polarization 
sensitivity in the transmittance/reflectivity of the detection optics. The G factor is 
measured by using a technique called ‘tail matching’ (23). A calibration dye is 
selected whose fluorescence lifetime (τ) is significantly longer than its rotational 
diffusion time (θ) and whose emission wavelength is similar to the samples that are 
being measured. Fluorescence emitted at times much greater than the rotational 
diffusion time is fully depolarized as any net orientation of excited molecules has 
decayed away. The ratio of the parallel and perpendicular fluorescence components at 
these long times then gives the relative sensitivity of the detection system to parallel 
and perpendicular light. 
  Intrinsic fluorescence has an emission peak in the range of 440-460nm and so 
we choose coumarin, which has an emission peak at 440nm, as our calibration dye. 
Coumarin has a fluorescence lifetime (~2.2ns) (Fig.2.6a) which is significantly longer 
than its rotational diffusion time (~120ps) (Fig.2.6b), hence a significant amount of 
fluorescence is emitted by the fluorophore that is depolarized. 
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Figure 2.6. G Factor determination using coumarin as a fluorescence standard. 
(a) Coumarin total fluorescence intensity decay (blue) and rotational anisotropy decay 
(red). (b) Parallel component (blue) and perpendicular component (red) of the total 
fluorescence decay. The time range taken for tail matching is indicated by T1 and T2. 
 
  The parallel and perpendicular fluorescence decay components are recorded 
(Fig.2.6 c and d) and a time window (T1 Æ T2) is selected near the end (tail) of the 
fluorescence decay over which the G factor is then calculated according to Eqn.(2.25). 
While the G factor is measured for each data measurement run, the typical value of the 
G factor ranges between 0.8 and 1.1.   
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2.4.7 Number of decay components 
  The number of exponential decay components used in a fit of lifetime decay is 
an area of some contention. If an a priori knowledge of the excited state dynamics 
gives reason to expect a specific number of decay components, then one can fix the   33
number of components. Often however, as in the case of tissue, there is no reason to 
expect a specific number of components. In such a case, the rule of thumb is to fit the 
decay with the minimum number of components that provides a good χ
2 (χ
2 < 1.3 (23)) 
and only marginal improvement in χ
2 (<0.2 (23)) with an additional fit component. 
Additionally, we can also use the residuals and the autocorrelation of the residuals to 
determine goodness of fit – both should appear as random fluctuations about 0 for a 
good fit. 
 
2.5 The hippocampal brain slice 
  The hippocampal slice has served for many years as a model ex vivo system 
for a variety of studies on activity dependent and metabolic phenomena. The well 
defined neural circuits make the hippocampus a convenient system for studying 
activity dependent phenomena. Furthermore, the susceptibility of the hippocampus to 
neurological diseases linked with dysfunctional energy metabolism provides further 
motivation for their study in ex vivo preparations of this system.  
 
2.5.1 Hippocampal slice architecture 
  The transverse hippocampal slice has a well defined structure (Fig. 2.7) 
consisting of three distinct cell layers, known as the CA1, CA3 and the dentate gyrus 
(DG). The cell bodies of these layers are indicated by the dashed white line. There are 
two axonal bundles (red): the mossy fibers which originate from the DG and synapse 
on the dendrites (yellow) of the CA3 layer, and the Schaeffer collaterals which 
connect the CA3 to the CA1 layer. 
  In our experiments utilizing electrophysiology on transverse hippocampal 
slices, stimulation across the Schaeffer collaterals provides a convenient spatial 
separation (~1mm) between the site of stimulation and that of the consequent synaptic   34
activity. This separation can be particularly valuable in optical recording of activity 
associated NADH fluorescence changes, where the stimulation electrode can be placed 
entirely outside the field of view.  
  Most of the metabolic imaging presented here is done in the CA1 layer. The 
CA1 and CA3 layer in turn have multiple regions or strata. The stratum oriens (SO) 
consists of axons that leave the cell layer to form synapses with other cell layers. CA3 
axons synapse with CA1 dendrites and CA1 axons leave the hippocampus entirely. 
The stratum pyramidale (SP) is a layer of neuronal cell bodies. The stratum radiatum 
(SR) and stratum lacunosum-moleculare (SLM) consist of axo-dendritic network with 
numerous synapses and scattered astrocytes. In the CA3, there is an additional layer, 
not obvious in Fig.(2.7) known as the stratum lucidum (SL) which consists of both 
dendrites and the mossy fibers entering the CA3 region. 
 
 
Figure 2.7 Architecture of the hippocampal slice. Scale bar is 1mm.   35
2.5.2 Sample Preparation 
2.5.2.1 Primary dissociated neuronal cultures 
  The hippocampi from neonate Sprague-Dawley rat pups were dissected in ice-
cold dissection buffer and removed and transferred into warmed (37 °C) Papain 
solution kept at 95% O2 and 5% CO2. The hippocampi were cut into thin slices and 
digested for 60 to 75 minutes by adding Papain enzyme. After digestion cells were 
washed, centrifuged, counted and diluted, dropped into appropriate dishes and placed 
in an incubator. The cells were cultured in phenol-red free growth media (Neurobasal 
A media, Gibco BRL). The media exhibited a significant (40% intensity of the 
intrinsic fluorescence in neurons) and broad fluorescence from 450 to 570 nm. One the 
first day ARA-C (5 µm) was applied to suppress cell division. From then on cells were 
fed twice a week by replacing half the media. The cells were grown on special dishes 
for imaging through a cover slip (Glass No. 1.5, thickness 0.17 mm, MatTek Corp.).  
For imaging the Neurobasal A media was replaced by Tyrode’s buffer (NaCl 135 mM, 
KCl 5 mM, MgCl2 1 mM, CaCl2 1.8 mM, Hepes 20 mM, BSA 0.5% ,and Glucose 10 
mM). The temperature of the culture dishes under the microscope was kept at 36°C by 
using an objective heater (Bioptechs Inc.) and heating the perfusate. For colocalization 
studies, the cells were stained with rhodamine123 100 nM (Molecular Probes) for 30 
min.  
 
2.5.2.2 Acute Hippocampal Slices 
  Transverse hippocampal slices were prepared from Sprague-Dawley rats (day 
14 to day 20) using a McIllwain tissue chopper or a Cambridge Vibratome according 
to the protocol described by Wang & Kass (24). The slices were incubated in artificial 
cerebrospinal fluid (ACSF) for 30 min to 1 h in a static bath chamber prior to imaging. 
The ingredients used for ACSF are NaCl 118 mM, KCl 3.0 mM, KH2PO4 1.0 mM,   36
MgSO4 1.0 mM, Glucose 20 mM, CaCl2 1.5 mM and NaHCO3 25 mM. Normoxic 
ACSF was oxygenated by constantly bubbling it with a gas mixture containing 95% 
O2 and 5% CO2. Hypoxic ACSF was similarly deoxygenated with a gas mixture 
containing 95% N2 and 5% CO2. ACSF solutions were kept in a static water bath at 
35°C from which they could be perfused into the slice chamber. 
  Slices were transferred into one of two tissue perfusion chambers depending 
upon the experiment to be performed (see below). The temperature in the chamber 
was controlled by a feed-back loop and maintained at 32-34 °C. A solution Heater SH-
27A (Warner Instruments Inc.) was used to warm ACSF as it flowed to the chamber. 
For colocalization studies, the slices were stained with rhodamine123 (200 nM) for 30 
min. For inducing of tissue hypoxia, the slices were perfused with hypoxic ACSF. 
 
2.5.3 Slice Maintenance: Perfusion Chambers 
  Different slice perfusion chambers were used depending on the specific 
requirements of the experiment. 
 
2.5.3.1 Open chamber  
  The open perfusion chamber (RC-27L, Warner Instruments Inc.) (Fig.(2.8)) 
was used for all experiments in which a precisely defined perfusate oxygen 
concentration was not required. These included imaging experiments dealing with 
electrophysiology or introduction of pharmacological agents such as CN or FCCP. 
  The perfusate PO2 cannot be precisely controlled in this chamber as the top 
surface of the fluid in the chamber is exposed to the air – allowing free exchange of 
oxygen with the perfusate. The equilibration with atmospheric PO2 is not complete 
however. Typically, normoxic ACSF (95% O2 + 5%CO2) is perfused into one end of 
the chamber, and decreases in PO2 from 0.95 atm to >~0.6 atm (450mmHg) by the   37
time it gets to the slice. Hypoxic ACSF (95% N2 + 5%CO2) on the other hand 
increases its PO2 from ~0 to <~0.2 atm (150mmHg) (Fig.2.9, blue curve). 
 
Figure 2.8 Open slice perfusion chamber. This chamber is often used for 
experiments involving electrophysiology. 
 
  While a PO2  much lower than the 0.2 atm provided by hypoxic ACSF is 
required to induce the normoxic-hypoxic transition in mitochondria – this transition is 
still observable due to the PO2 decrease as a function of depth into the slice (see 
Section 2.6). A significant response to hypoxia is observed at typical imaging depths 
(50-100µm) (Fig.2.9) – causing a ~15% increase in the NADH fluorescence and a 
collapse of the stimulation induced electrical activity (EPSP amplitude). The 
fluorescence increase on the lower surface of the slice is greater (~35-50%) due to less 
equilibration of the perfusate PO2 with air. 
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Figure 2.9 Hypoxia induced metabolic inhibition is possible even in an open slice 
chamber. Reducing the perfusate PO2, combined with the natural oxygen gradient in 
tissue enables a hypoxic response in deep tissue. 
 
2.5.3.2 Closed chamber   
  The closed chamber (Fig. 2.10) was designed for experiments in which the PO2 
of the perfusate must be well defined (e.g. Section 2.6). Both normoxic and hypoxic 
ACSF are bubbled until the desired PO2 is reached. They are then loaded into airtight 
glass syringes (Gastight 100ml, Hamilton) from which they are perfused into the 
chamber by programmable pumps (Pump 22, Harvard Apparatus) through oxygen 
impermeable Saran tubing. The PO2 in the chamber is set by the relative flow rates of 
the normoxic and hypoxic ACSF. The small volume (~0.18 ml) of the slice chamber 
ensures a fast solution exchange time (<10s) and therefore enables rapid changes in 
the chamber PO2. For example, during the normoxic to hypoxic transition, the 
chamber PO2 falls from 0.95 atm to <0.05atm in ~30s.  
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Figure 2.10 Closed slice perfusion chamber. This chamber enables a more precise 
control of perfusate PO2 while also allowing fast exchange times. 
 
  Being able to step the PO2 rapidly ensures that any temporal dynamics of the 
NADH response to changing PO2 are solely biological in nature and do not reflect a 
slow solution exchange time. Furthermore, the rapid exchange time ensures that the 
entire slice experiences a change in PO2 essentially simultaneously – and hence there 
are no spatial heterogeneities of the NADH response due to diffusion of the perfusate. 
 
2.5.4 Surface damage due to preparation 
  During the process of slice preparation it is inevitable that neurons near the 
surface of the slice will be physically damaged. Slicing through the dendritic network 
of cells results in a catastrophic loss of homeostasis and cell death in a time and depth 
dependent manner (25). In order to do valid functional imaging in brain slices, it is 
therefore necessary to image deeper than this superficial damage. Wide field   40
fluorescence detection in the brain slice preparation is problematic as the detected 
fluorescence is dominated (due to low penetration of the excitation light) by the 
fluorescence of superficial tissue, which is damaged. 
 
 
Figure 2.11 Live-Dead assay of depth dependent cell viability. The Live-Dead stain 
reveals that at a depth greater than ~30 microns, there is >90% cell survival for up to 
~5 hours.  
 
  To assess the extent of the superficial damage, we used a commercial viability 
assay (Live/Dead Cell Viability Kit, Molecular Probes) (Fig. 2.11) in which Ethidium 
bromide (red) stains the nuclei of dead cells, and Calcein AM (green) stains the cell 
bodies of healthy cells. As expected, we found that the fraction of dead cells decreased 
with depth into the slice, while the number of dead cells at all depths increased with 
time. In general, imaging deeper than 30µm ensures a >90% cell viability for up to   41
~5hours. All imaging in this work was therefore done deeper than 30µm and slices 
were typically used within 4-5 hours of preparation. 
 
2.5.6 Photobleaching & Photodamage 
  Intrinsic NADH undergoes photobleaching upon excitation. The bulk of the 
photobleaching product is simply the non-fluorescent NAD
+, while a small fraction 
consists of irreversibly generated non-fluorescent dimers and trimers of NADH (26). 
The photooxidation of NADH can be thought of as a perturbation of the cellular 
metabolic state, which is a function of the NADH/NAD+ ratio. For low excitation 
doses, this bleaching is generally reversible as the cell naturally reestablishes its 
normal metabolic state. At higher excitation doses, the bleaching can become 
irreversible, both due to the irreversible accumulation of the dimers and trimers, as 
well as the excessive perturbation of the cellular metabolic state beyond its ability to 
recover. Balaban et al (26) have shown in cardiac myocytes that bleaching the intrinsic 
fluorescence to less than 70% of its baseline level leads to an incomplete recovery of 
the baseline fluorescence, indicating the significant production of irreversibly 
bleached products. 
  Under each of our imaging protocols, control exposures were done to assess 
the bleaching.  In all imaging protocols, the intrinsic fluorescence signal underwent a 
slow decrease of less than 10% over the duration of our measurement (10-20 min.). 
Changes in morphology and induced broad autofluorescence characteristic of severe 
photodamage were not observed (see Section 3.1.5). The response of intrinsic 
fluorescence to changes in the metabolic state was both reversible and repeatable, 
indicating that our experiments did not cause irreversible short term damage.   
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2.6 Diffusion of oxygen into tissue 
2.6.1 The reaction diffusion equation 
  Oxygen diffusion into tissue is generally described by the “reaction-diffusion 
equation” 
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Where D is the diffusion coefficient of oxygen in tissue, P(r) is the partial pressure of 
oxygen at a point r, M is the rate of an irreversible chemical reaction in which oxygen 
is consumed and S is the solubility coefficient of oxygen in tissue (~1.12 µmol/cm
3 
atm). The solubility coefficient relates the partial pressure of oxygen to its 
concentration (C=SP). The product DS is often referred to in the literature as the 
“Krogh diffusion constant”(27) and is taken to be a constant for a given tissue. We 
will also make this approximation, however, it has been suggested that there is 
considerable heterogeneity of diffusion in tissue (28), with more rapid diffusion 
through intracellular pathways of greater oxygen solubility. These pathways are 
thought to have higher lipid fractions e.g. regions of greater mitochondrial population. 
The experiments done here are largely performed in the stratum radiatum of the CA1 
hippocampal layer. This region has a homogenous distribution of mitochondria, 
indicating that the assumption of a spatially invariant solubility is a reasonable 
approximation in our system.   
  There are a number of different models of tissue oxygen diffusion which differ 
in their functional form of the oxygen consumption rate (M). The four most commonly 
used models of oxygen consumption in tissue are the following. 
1. Zero order kinetics (27,29,30) 
 
0 (constant) for  0
0 for  0
MM P
M P
= >
= =
 (2.27) 
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2. First order kinetics 
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3. Mixed zero and first order kinetics 
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4. Michaelis-Menten kinetics (31) 
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  Buerk and Saidel (29) have tested all four of these models on actual 
measurements of oxygen profiles in both brain and liver tissue slices and found the 
best fit to be from the Michaelis-Menten model. Their goodness of fit parameters for 
these four models are summarized in Table 2.2. 
 
Table 2.2 Accuracy of models of oxygen consumption kinetics 
Model #  free 
Parameters 
χ
2
 (Brain)  χ
2
 (Liver) 
Zeroth Order  1  0.4638  0.2901 
First Order  2  9.997 x 10
-2 4.326 x 10
-2
Mixed  3  3.475 x 10
-3 1.033 x 10
-2
Michaelis-
Menten 
3  3.253 x 10
-3 5.178 x 10
-3
 
  Historically, it is common to see mention of a “critical PO2” as well as of a Pm. 
The “critical PO2” is defined in the context of the mixed kinetic model – it is that PO2 
at which the rate of O2 consumption switches from first order to zeroth order. Pm is   44
used in more recent literature, and is defined in the context of the Michaelis-Menten 
model as that PO2 at which the rate of oxygen consumption drops to ½ of its 
maximum. Depending on the experiment, the values of the critical PO2 or Pm typically 
lie between 0.01 and 2 torr (29,32).  
  The exact equation for the O2 consumption rate by the mitochondrial electron 
transport chain was derived by Wilson et al(7).  
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Where k2, k-2, K, α and β are various enzyme constants of the electron transport chain 
and [c
2+] and [a3T] are the concentrations of reduced cytochrome oxidase and 
cytochrome a3. What is important here is that this equation for oxygen consumption is 
indeed of the Michaelis-Menten functional form (Eqn.(2.30)).  
 
2.6.2 Approximations to the reaction diffusion equation 
  The tissue perfusion chambers maintain an oxygen gradient in tissue slices by 
maintaining a constant oxygen concentration in the surrounding perfusate. To estimate 
this gradient therefore, entails solving the steady state reaction diffusion equation, i.e. 
setting   in Eqn.(2.26). Furthermore, a hippocampal slice is typically 2mm x 
3mm in cross sectional area but only 300µm thick. The area that we most frequently 
image – the CA1 stratum radiatum - is a dendritic network near the center of the 
hippocampal slice. In this area, since our imaging depth is much smaller than the 
cross-sectional area, we can approximate the hippocampal slice as a semi-infinite slab 
of tissue. This reduces the dimensionality of the reaction diffusion equation. The 
resulting one dimensional steady state reaction diffusion equation with Michaelis-
Menten consumption kinetics is then given by: 
/ Pt ∂∂ =  45
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  Furthermore, while the reaction diffusion equation with Michaelis-Menten 
kinetics is not analytically solvable, it can be analytically solved in two regimes of 
approximation: 
 
1.  P<<Pm; The reaction-diffusion equation reduces to first order kinetics. 
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2.  P>>Pm; The reaction-diffusion equation reduces to zero order kinetics. 
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As we have stated above, Pm is typically very low (0.01-2 torr). Imaging and 
spectroscopy done throughout this work are done at depths of 30-100µm. Tissue 
oxygen measurements made with oxygen electrodes (27,30), suggest the PO2 values 
typical of our imaging depths in brain slices in a normoxic perfusate (10-100 torr) are 
substantially larger than this Pm. Hence for depths pertinent to imaging, we can 
approximate P>>Pm and the reaction diffusion equation reduces to zero order kinetics 
(Eqn.(2.34)).    
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2.6.3 Steady state oxygen profile in a brain slice  
 
 
Figure 2.12 Semi-infinite approximation of a brain slice to calculate the oxygen 
gradient. To calculate the oxygen gradient in a slice, we approximate it as a semi-
infinite slab, surrounded by perfusate with a well define oxygen level. 
 
  We approximate a typical brain slice as a semi-infinite slice (x,y:infinite; -L/2≤ 
z ≤ L/2), of thickness L=300µm, whose top and bottom are open to the perfusate 
(Fig.(2.12)). The perfusate PO2 (Pp) is maintained constant at a value depending on the 
desired metabolic state and the perfusion chamber. In the open slice chamber, the 
normoxic PO2 is ~0.6 atm and the hypoxic PO2 is ~0.2 atm. In the closed slice 
chamber, the normoxic PO2 is ~0.8 atm while the hypoxic PO2 is ~0.05 atm. Under 
these conditions, the oxygen profile is then defined by: 
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Where M0 has been measured to be 4.4umol O2/min cm
3 (29) and DS is ~ 0.6 x 10
-3 
µmol O2/min cm atm. The solution to Eqn.(2.35) is: 
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This solution is plotted as a function of depth and perfusate PO2 in Fig.(2.13).  
 
Figure 2.13 Oxygen profile in a brain slice. The oxygen profile in a living brain slice 
depends on the aerobic consumption rate of the tissue and the perfusate PO2. Curves 
are shown for open and closed perfusion chambers (see above) with normoxic and 
hypoxic buffers. 
 
  In the normoxic open chamber, the oxygen level reaches 0 by ~75µm into the 
slice. During hypoxia, the oxygen level reaches 0 by ~20µm into the slice. Hence 
imaging at depths of 40-70 µm is well suited to monitoring fluorescence changes 
associated with the normoxic to hypoxic metabolic transition. In the closed chamber,   48
at maximal bath PO2, the slice is nearly completely normoxic – the oxygen drops to 
the critical point briefly near the center of the slice. In the hypoxic closed chamber, the 
oxygen drops to 0 within a few microns. It should be remarked that the PO2 does not 
actually reach zero since at the critical PO2 of about 0.001 atm, the oxygen 
consumption switches to first order kinetics and the PO2 decays as an exponential.  49
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Chapter Three 
Intrinsic Fluorescence in Brain Tissue 
 
 
3.1 Sources of intrinsic signals (other than NADH) 
  There are a number of known sources of fluorescence and second harmonic 
signals that are found intrinsically present in native, unstained tissues. These intrinsic 
fluorophores are typically very weak and hence fluorescence imaging of externally 
applied dyes or genetically targeted fluorescent proteins observe this intrinsic 
fluorescence as a weak background signal. However, since our work specifically deals 
with intrinsic NADH fluorescence, we must consider the other possible intrinsic 
sources. The discussion below considers the more common known fluorophores 
associated with neural tissue and demonstrates that under specific excitation and 
emission conditions, the intrinsic fluorescence is predominately due to NAD(P)H. 
 
 
 
 
51   52
3.1.1 Amino acids 
  Many proteins are intrinsically fluorescent due to the presence of tryptophan, 
tyrosine and/or phenylalanine residues. These molecules typically absorb in the far 
UV (240-300nm) and emit in the near UV (250-400nm) (Table 3.1) (1). 
 
Table 3.1 Fluorescent amino acids 
  Excitation (nm)  Emission (nm) 
Phenylalanine 260  282 
Tyrosine 275  304 
Tryptophan 295  353 
 
Two-photon excitation spectra of both tryptophan and tyrosine are somewhat different 
from their one-photon counterparts – this effect is more pronounced in the case of 
tryptophan. Both excitation spectra are however negligible by ~620nm (2). Hence, 
two-photon excited fluorescence of proteins is not significant at wavelengths typically 
used for two-photon imaging (700-1000nm).  
 
3.1.2 Retinoids 
  Retinoids are vitamin A derivatives that are known to play roles in the 
development and maintenance of several tissues. In the brain, the primary retinoid is 
retinoic acid (RA), which binds to a family of nuclear retinoic acid receptors (RARs) 
to regulate transcription. Retinoic acid is known to play a role in neurogenesis and 
differentiation in the developing and adult central nervous system (3). RA also plays a 
role in synaptic plasticity and neurogenesis in the adult rat hippocampus (4,5). In fact,   53
the hippocampus not only uses retinoids, but has also been shown to synthesize 
retinoids – primarily in the dentate gyrus, but also in the layers CA1-3 (5).  
  The two-photon action cross section of retinol (vitamin A alcohol) peaks near 
700nm at 0.07GM (6) – comparable to that of NADH (~0.09GM at 700nm) (7). The 
emission peak is ~480nm – also very similar to NADH. All-trans retinoic acid excites 
at 365nm and emits in the range of 370nm-600nm with a peak at ~400nm (the 2P 
action cross section has not been measured). Upon binding to RAR-gamma, the peak 
is red-shifted to ~430nm and the emission is enhanced by ~2-3X (8). The absolute 
concentrations of retinoids in the brain have not been measured. However, the retinol 
and RA concentrations in the liver (believed to have relatively high retinoid levels) 
have been measured to be on the order of ~10nmol/g and 1nmol/g wet weight 
respectively. Assuming the tissue density to be approximately that of water, these 
concentrations correspond to 10µM for retinol and 1µM for RA. If the concentration 
of retinol and/or retinoic acid in brain is even comparable to that in liver, then 
retinoids would be present in the hippocampus at much lower concentrations than 
NADH (~100µM). Taken together with the fact that the two-photon action cross 
sections of retinol and NADH are comparable, the much lower retinoid concentration 
would make retinoids a small component of the total intrinsic neuronal fluorescence. 
  Furthermore, since RA is a nuclear transcription regulator, its presence should 
be revealed by a nuclear fluorescence in the cell layers of the hippocampus. In our 
observations, the hippocampal nuclear fluorescence has been exceedingly weak - 
typically on the level of background noise – indicating that the RA contribution to the 
intrinsic fluorescence is minimal.  
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3.1.3 Lipofuscin 
  Lipofuscin is a yellowish-brown pigment that accumulates slowly with age 
into small, dense granules about 1-5µm in diameter (9). This substance is thought to 
be a product of lipid peroxidation in post-mitotic cells, initiated by reactive oxide 
species and followed by non-specific decomposition of the products into fluorescent 
compounds. The final composition of lipofuscin, and therefore its spectral properties, 
is not well defined. Typically however, lipofuscin granules excite with UV light 
(~360nm) and have emission spectra that can range from blue to yellow (9).     
  In the rat brain, the hippocampus is among the first structures to begin showing 
lipofuscin accumulation as a function of age and accumulates it at the highest rate of 
any brain structure. However, this accumulation does not begin until about 8 weeks of 
age (10). Given that our experiments were done on rats of 2-3 weeks of age, lipofuscin 
is not a likely contributor to our fluorescence signal.   
 
3.1.4 Microtubules 
  Microtubules are sources of non-linear scattering at exactly half the excitation 
wavelength – known as second harmonic generation (SHG). There is sufficient 
parallel alignment of microtubules in the axons of neurons that a significant SHG 
signal can be detected (11). In the hippocampus, there is a strong SHG signal 
generated from the axon bundles that run between the dentate gyrus and the CA3 
layer, known as the mossy fibers (Fig. (3.1)). A much weaker signal is also detectable 
from the Schaeffer collaterals – the bundle of axons running between the CA3 and 
CA1 layers. While the intensity of the SHG signal in the mossy fibers is comparable to 
that of the intrinsic fluorescence of the surrounding neuropil under 740nm excitation, 
the SHG is directed almost entirely (>90%) in the forward direction. Since our 
fluorescence detection path is in the backwards direction, neither our images nor   55
wavelength resolved spectroscopy have shown a significant contribution from 
microtubule SHG. 
 
Figure 3.1 SHG from aligned microtubules in axons. Image of the intrinsic 
fluorescence (red) and SHG (green) arising from aligned microtubules in axons. Scale 
bar is 1mm.   
   
3.1.5 Induced autofluorescence 
  Overexposure of tissue to exciting radiation can lead to photodamage. At low 
to moderate excitation doses, this damage is manifest as a simple photobleaching of 
the intrinsic fluorescence. In the case of NADH, the majority of the bleaching product 
is simply the non-fluorescent oxidized dinucleotide: NAD
+ (12).  
  At a sufficiently high excitation dose, it is possible to induce new fluorescence 
in tissue. Although there has been little work to establish the composition of these   56
autofluorescent compounds, it is generally believed that they are created by the cross-
linking of photo-excited molecules (e.g. proteins). Spots of photodamage induced 
autofluorescence tend to appear as blebs with an ill defined structure (Fig.3.2) and 
emission spectrum.  
 
 
 
Figure 3.2 Induced autofluorescence due to severe photodamage. Induced 
autofluorescent blebs are (B) morphologically and (C) spectrally ill defined. The 
excitation beam (~45mW) was parked on a hippocampal neuron for >10s. The signal 
cut off at >650nm is due to a cut off in the transmission of the detection optics.     57
  This type of damage can generally be avoided by using the minimum 
excitation power required for acceptable image quality. Under imaging conditions 
typical of our time series studies in the hippocampus, we observe a ~10% bleach in the 
NADH intensity throughout the course of the time series, and no induced 
autofluorescence 
 
3.1.6 NADPH 
  Nicotinamide adenine dinucleotide phosphate is virtually identical in structure 
to NADH with the exception of an extra phosphate group in the bridge between the 
nicotinamide and adenine rings. Like NADH, the fluorescent NADPH also forms a 
redox pair with its non-fluorescent oxidized form NADP
+. NADH and NADPH are 
distinct in their biochemical roles: NADH being largely restricted to energy 
metabolism and NADPH largely to reductive biosynthesis (13). However, there is no 
known photophysical means of discriminating NADH and NADPH either in solution 
(14) or in biological samples (15). Therefore, it is a common practice to assign 
intrinsic blue tissue fluorescence to “NAD(P)H” without considering the relative 
contributions of the two reduced pyridine nucleotides.  
  The concentrations of pyridine nucleotides have been measured by HPLC in 
mouse hippocampus (15). It was found that the total concentration of 
diphosphopyridine nucleotides (NADH and NAD
+) is greater than that of 
triphospopyridine nucleotides (NADPH and NADP
+) by a factor of ~10. The 
concentration of the reduced fluorescent species NADH was found to be ~5 times 
greater than that of the fluorescent NADPH. Furthermore, the enhancement of 
mitochondrial NADH quantum yield due to environmental effects was estimated to be 
a factor of 1.25-2.5 greater than that of NADPH (16). This implies that the   58
contribution of NADPH to the intrinsic fluorescence, while not insignificant, 
represents a small fraction of the NADH contribution.  
  Furthermore, tissue analyses of pyridine nucleotide content in heart and liver 
have confirmed that the fluorescence changes during the normoxic-anoxic transition 
are dominated by changes in NADH with only a minor (~10%) contribution of 
NADPH (17). Hence, NADPH represents a minor fluorescence background that is 
roughly constant with respect to metabolic perturbations. 
 
3.1.7 Flavins 
  These are a family of compounds that are derivatives of or contain the flavin 
mononucleotide (FMN) group. Of particular relevance here flavin adenine 
dinucleotide (FAD), like NADH, is a fluorescent redox molecule. The oxidized state 
(FAD
+) is fluorescent, the reduced state (FADH2) is non-fluorescent and its oxidation 
state is a function of the metabolic state of the cell (18). The FAD
+ and NADH 
fluorescence emissions are spectrally distinct. The flavin signal that we observe in the 
hippocampus has an emission peak (~550nm) significantly higher than the NADH 
emission peak, and can therefore be easily discriminated from the NADH signal 
through a judicious choice of emission filter. Flavin detection and filtering is discussed 
further in Section (3.4) and so we shall not discuss it further here.  
 
3.2 Identification of NADH 
  A number of intrinsic fluorophores are intrinsically present in neural tissue. 
However as we have discussed above, given the conditions of our excitation, emission 
filtering, detection geometry and brain region selection, the only fluorophores that are 
likely to contribute significantly to our images are NADH, NADPH and flavins. To 
strengthen the argument that the dominant fluorophore in these studies is NADH, we   59
provide arguments based on the morphology of the fluorescence, its functional 
behavior, and its steady state (wavelength resolved) fluorescence spectrum.  
 
3.2.1 Morphology of intrinsic fluorescence 
3.2.1.1 Cultured neural cells  
  The intracellular intrinsic fluorescence under our excitation (720nm) and 
emission (410-490 nm) conditions in cultured neurons and glial cells exhibits a pattern 
of bright punctuate organelles scattered throughout the dim cytoplasm (see Fig.3.3). 
  
 
Figure 3.3 Intrinsic fluorescence in cultured neurons and glial cells. Bright 
punctuate spots are mitochondria, while the cytosol is diffuse and dim. Nuclei appear 
as dim, large and circular regions. Scale bar is 50µm.   60
  These punctuate organelles are typically between 0.5-1 µM in width and vary 
in their length from being short and approximately spherical to slender and highly 
elongated. The fluorescence in the rest of the cytoplasm is homogenous and dim. The 
nuclei can clearly be identified as circular or oval structures with a diameter of ~10 
µm that exhibit a homogenous fluorescence slightly dimmer than that of the 
cytoplasm.  
  The morphology of the bright, punctuate organelles is consistent with that of 
mitochondria. To test this identification, we have utilized the conventional 
mitochondrial dye, rhodamine 123 (Rh123; Molecular Probes). Cultures of 
hippocampal neurons and glial cells were stained with Rh123 (~100nM) and the 
Rh123 and intrinsic fluorescence were imaged simultaneously (Fig.3.4). Intrinsic 
fluorescence (red pseudocolor, Fig.(3.4a)) and Rh123 (green pseudocolor, Fig.(3.4b)) 
images show excellent co-localization (yellow, Fig.(3.4c)), indicating that these 
punctuate objects of high intrinsic fluorescence are indeed mitochondria. The cross 
talk between intracellular autofluorescence (peak at ~440 nm) and Rh123 (peak at 530 
nm) channels is negligible due to the difference in their fluorescence spectra. 
 
3.2.1.2 Acute hippocampal slices 
  In hippocampal slices, neurons are organized in a much more compact and 
interwoven 3-dimensional network than in cultures and hence it is difficult to clearly 
distinguish punctuate mitochondria and smooth cytoplasm. Nonetheless, the intrinsic 
and Rh123 fluorescence images (Fig.(3.4d-f)) still exhibit a co-localized granularity 
similar to that in cultured cells.    61
 
Figure 3.4 Colocalization of NADH and Rh123 in cultured neurons and 
hippocampal slices. Intrinsic fluorescence (red) and Rh123 (green) show excellent 
colocalization (yellow) in cultured cells (A-C), single hippocampal neurons (D-F) and 
macroscopic hippocampal layers (G-I). Scale bars: top row - 5µm, middle row - 5µm, 
bottom row - 50µm.   
 
  The macroscopic pattern of the intrinsic fluorescence in the hippocampus 
shows a well defined structure. In the region CA1, the fluorescence is brightest in the 
molecular layer, intermediate in the stratum radiatum, lowest in the stratum 
pyramidale and intermediate in the stratum oriens.  The pattern in the region CA3 
(Fig.(3.4g-i)) is quite different. Note the layered pattern, with bright fluorescence in 
the molecular layer and in the stratum oriens and low fluorescence in the pyramidal   62
layer and the stratum radiatum. This layer of low fluorescence is in turn divided by a 
thin layer of intermediate fluorescence that is not present in region CA1. Hence, even 
though it is more difficult in slices to correlate single Rh123 stained mitochondria with 
intrinsically fluorescent granules, we can readily see similarity between the 
macroscopic mitochondrial distribution and the banding pattern of the intrinsic 
fluorescence.  
  The morphology of the intrinsic fluorescence establishes a mitochondrial 
origin for the majority of the intrinsic fluorescence.  
 
3.2.2 Pharmacological response of intrinsic fluorescence  
  The response of the intracellular NADH level to specific pharmacological 
manipulations has been well established (see Section 2.1). In mitochondria, the 
electron transport chain (ETC) is the only oxidizer of NADH, and hence 
pharmacological manipulation of the flux through the ETC offers a direct and 
predictable means of altering the mitochondrial NADH/NAD
+ ratio. Conversely, 
measuring the response of cellular fluorescence to these specific pharmacological 
manipulations offers a means to test for the presence of NADH. 
  Two classes of effects are used here to test for NADH – ETC inhibition and 
uncoupling of oxidative phosphorylation (see Section 2.1 for underlying biochemical 
mechanisms). Inhibition of the ETC is done with cyanide or hypoxia and results in an 
increase in the NADH fluorescence. Uncoupling is done with FCCP – a weak 
lipophilic acid that collapses the mitochondrial inner membrane potential and leads to 
a decrease in mitochondrial NADH.     
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3.2.2.1 Response of cultured neurons and glial cells to inhibition and uncoupling 
  In cultured neural cells, perfusion with cyanide for 5 minutes leads to a 
completely reversible increase with no apparent adverse effects (Fig. (3.5)). On the 
other hand, a 5 minute perfusion with FCCP was not completely reversible which 
might be explained by the fact that FCCP is a weak lipophilic acid that gets taken up 
into the mitochondrial membrane and is slow to diffuse out of the membrane.  
 
Figure 3.5 Response of intrinsic fluorescence in cultured neurons to inhibition 
and uncoupling. Metabolic inhibition with cyanide leads to a fluorescence increase 
while uncoupling with FCCP leads to a fluorescence decrease. This response is 
consistent with the intrinsic fluorescence arising from NADH. 
 
3.2.2.2 Response of intrinsic fluorescence in brain slices to cyanide 
  In brain slices, reversible inhibition of the ETC in brain slices was possible 
with both cyanide and hypoxia. However, it was not practical to use the uncoupler   64
FCCP as this lipophilic drug is rapidly absorbed into the highly lipid rich neuropil and 
hence does not penetrate to any significant depth into the tissue. 
  A known concentration of cyanide is added to the perfusate for a brief period 
(5 min) in order to induce a reversible inhibition of the ETC. The response of the brain 
slice is a transient increase in the intrinsic fluorescence in the soma and the processes, 
while the nuclei remain dark (Fig.(3.6)).  
 
 
Figure 3.6 Response of hippocampal brain slice to cyanide. Hippocampal neurons 
(A) undergo a transient fluorescence increase in response to cyanide (B). The 
fluorescence returns to near baseline levels (C) upon reperfusion. Contrast has been 
enhanced for clarity of presentation. Scale bar is 50µm. 
 
  The average fluorescence from the slice is shown in Fig.(3.7) as a function of 
time for a range of cyanide doses. Each fluorescence response exhibits a rapid increase 
to its peak upon introduction of cyanide followed by a somewhat slower decay of the 
fluorescence after washing the cyanide out of the surrounding bath.    65
 
Figure 3.7 Temporal response of brain slice intrinsic fluorescence to cyanide.  
 
  The magnitude of the NADH fluorescence response to cyanide was dose 
dependent. The response peak increases with increasing perfusate cyanide 
concentration (Fig.(3.8)) with a saturation beginning to occur at [CN] ~ 1mM. This 
saturation behavior is characteristic of phenomena associated with competitive binding 
and implies that at this perfusate concentration of cyanide, essentially all oxygen 
binding sites in complex IV molecules are binding cyanide instead and hence 
inhibition of the ETC is maximal.   66
 
Figure 3.8 Dose dependence of intrinsic fluorescence to cyanide. Saturation of the 
peak response at high [CN] occurs due to saturation of oxygen binding sites by 
cyanide. 
  
3.2.2.2 Oxygen dependence of intrinsic fluorescence in brain slices   
  The oxygen partial pressure (PO2) of the surrounding perfusate was also varied 
to test the dependence of the intrinsic fluorescence on oxygen. Images were recorded 
40-50µm within the brain slice while the oxygen level was recorded in the perfusate 
surrounding the tissue while. Since actively respiring tissue consumes oxygen, there is 
some attenuation of the oxygen partial pressure between the level in the perfusate and 
that at the imaging depth (see Section 2.5). Based on oxygen diffusion gradients 
measured in brain slices, we estimate the PO2 at typical imaging depths to be 30-50% 
lower than the perfusate partial pressure.   67
  The fluorescence of the brain slice in response to a 5 min. episode of hypoxia 
(PO2 Æ 0) shows both a rapid rise and rapid return to baseline level (Fig.(3.9)). This 
rapid response reflects the fact that this process is a simple substrate removal with no 
more complicated binding kinetics.  
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Figure 3.9 Response of brain slice intrinsic fluorescence to transient hypoxia 
  Reducing the substrate oxygen level in a graded manner (Fig.(3.10a)) shows 
that the fluorescence level is relatively insensitive to the perfusate oxygen over a large 
range. Between ~0.9 atm and 0.2 atm perfusate PO2 there is only a ~5% increase in the 
average fluorescence of the brain slice. A rapid increase in the fluorescence begins 
only below 0.2 atm perfusate PO2. The dependence of NADH fluorescence on PO2 
reveals a saturation effect at high PO2 (Fig.(3.10b)) – expected from Michaelis-
Menten enzyme kinetics.    68
 
Figure 3.10 Bath oxygen dependence of intrinsic fluorescence. Graded hypoxia (A) 
reveals an insensitivity of fluorescence to a large range of high bath PO2. The PO2 
dependence of intrinsic fluorescence (B) reveals saturation at high PO2.  
 
3.2.3 Steady state (wavelength resolved) spectroscopy of intrinsic fluorescence 
    We have confirmed that the observed emission in brain slices is 2P-
fluorescence by measuring its quadratic dependence on the excitation power 
(Fig.(3.11)). The quadratic dependence implies that both saturation and   69
photobleaching of the intrinsic intracellular fluorophore do not occur under our 
imaging conditions. Deviation from the I
2 dependence due to fluorophore excitation 
saturation effects does occur at higher excitation powers. This saturation regime can 
easily be avoided by using the lowest power possible with acceptable signal to noise. 
 
Figure 3.11 Power dependence of aqueous NADH fluorescence and intrinsic 
fluorescence. The quadratic dependence on excitation power of the fluorescence of 
aqueous NADH and the intrinsic hippocampal fluorescence reveal a two-photon 
excitation process. Deviation due to saturation effects does occur at high power 
however.  
 
  Two-photon emission spectra of the intrinsic fluorescence from the CA1 
stratum radiatum were compared to the emission spectrum of aqueous NADH 
(Fig.3.12). The 2P-emission maximum of aqueous NADH is ~460 nm at pH 7.4 while 
the tissue spectrum consists of two distinct peaks. The blue peak, which dominates 
(~90%) the tissue fluorescence, is blue shifted (by ~8nm) with respect to aqueous   70
NADH.  The yellow peak (at 560-570nm) is likely due to flavins (19,20). Upon 
hypoxia, we found that the blue peak was enhanced by ~44% while the yellow peak 
actually decreased in amplitude by ~34% (Fig.3.13).  
 
Figure 3.12 Spectroscopic identification of intrinsic NADH. Steady state 
wavelength resolved fluorescence spectra from normoxic (blue) and hypoxic (red) 
brain slices strongly resemble the spectrum from aqueous NADH (black). There is, 
however a slight blue shift of the tissue spectrum and a yellow flavin peak. The 
vertical lines are the bounds of our emission filter to select the blue peak.  
 
  This is consistent with the known inverse behavior of flavin and NADH 
fluorescence signals in response to hypoxia (18,21). FAD
+ (fluorescent) in complex 1 
of the ETC accepts reducing equivalents (H
+ + 2e
-) from mitochondrial NADH, 
generating FADH2 (non-fluorescent) and in turn passing those reducing equivalents   71
down the ETC - ultimately to oxygen. With the withdrawal of oxygen, there is an 
accumulation of the non-fluorescent FADH2 and hence the flavin fluorescence is 
reduced. In practice, we select our emission filters to reduce the flavin contribution to 
the integrated fluorescence to <4% in the normoxic state and <1% in the hypoxic state. 
 
Figure 3.13 Response of the yellow tissue fluorescence to hypoxia. The normoxic 
yellow fluorescence peak (blue) from a brain slice decreases upon hypoxia (red). This 
behavior and its emission peak are consistent with this component arising from 
flavins. 
 
  The blue peak of the intrinsic fluorescence spectrum is blue shifted with 
respect to aqueous NADH. This can be explained by the effect of enzyme-binding on 
NADH fluorescence. Enzyme binding has the effect of enhancing and blue shifting the 
fluorescence of NADH. To demonstrate the effect of enzyme binding on NADH 
fluorescence, we titrated NADH against mitochondrial malate dehydrogenase   72
(mMDH) – a mitochondrial NADH binding enzyme. The titration of NADH (10µM) 
with increasing concentrations of mMDH resulted in a 2.2 fold fluorescence 
enhancement, accompanied by a 13 nm blue shift of the emission peak (Fig.(3.14), 
solid squares).   
 
Figure 3.14 Effect of enzyme binding on NADH fluorescence. Binding to 
mitochondrial malate dehydrogenase causes an enhancement and a blue shift of 
NADH fluorescence. 
  
  The titration also yields a dissociation constant of ~4.7 µM at pH 7, in 
reasonable agreement with an earlier report (~3.8 µM at pH 7.5) (22). There are many 
intracellular NADH binding dehydrogenases and each produces its own specific 
fluorescence enhancement (up to 10x) and blue shift (up to ~30nm, (19)) due to 
specific interactions between the fluorescent nicotinamide ring and neighboring 
groups in the binding site. The measurement summarized in Fig.(3.14) shows that the   73
~8nm blue shift of the intracellular fluorescence spectrum with respect to the aqueous 
NADH spectrum can be readily accounted for by the enzyme binding of intracellular 
NADH. 
  The exact fraction of intracellular NADH that is bound to enzymes is a 
question of some uncertainty. While others have estimated that intracellular NADH is 
almost completely bound to enzymes (23), we will present evidence in Chapter 5 that 
the fraction of free NADH is indeed significant. However, there is general agreement 
that, due to the large fluorescence enhancement caused by enzyme binding, the 
majority of cellular NADH fluorescence is from NADH bound to cytosolic and 
mitochondrial dehydrogenases.  
 
3.3 Intrinsic fluorescence in astrocytes  versus  neuropil      
3.3.1 Glial cells in the hippocampus 
  There are roughly twice as many glial cells in the central nervous system as 
there are neurons, and their distribution amongst the different regions of the brain is 
highly heterogeneous. Glial cells are morphologically and functionally distinct from 
neurons. In the hippocampus, the primary glial types are astrocytes and microglia. 
Microglia act as the brain’s immune system and are not of particular interest in this 
work. Astrocytes on the other hand are intimately involved with mediating the flow of 
metabolites from capillaries to neurons and with bearing the metabolic cost of neural 
activity. In light of the particular importance of astrocytes to neurometabolic coupling, 
it is worthwhile to explore the ability to distinguish them by their intrinsic 
fluorescence.   
  Images of the intrinsic fluorescence in the hippocampus reveal astrocytes as 
bright, stellate cells with cell bodies much smaller (~10µm) than those of neurons 
(Fig.3.15).   74
 
Figure 3.15 Intrinsic fluorescence image showing glia in the neuropil. Bright, 
small, stellate astrocytes are indicated by arrows in the SR of the hippocampal CA1 
layer. Scale bar is 40µm. 
 
  Typically, only the astrocyte body and its proximal processes are discernible 
from the surrounding neuropil, while the finer processes cannot be distinguished. 
These cells appear scattered rather sparsely throughout the neuropil. Walz & Lang 
used immunolabelling of astrocytes to estimate their numerical density in the CA1 
stratum radiatum to be 43.3 x 10
3 mm
-3 (24). This numerical density corresponds to ~1 
astrocyte per 100x100µm image region (assuming ~2µm depth of focus), in good 
agreement with our NADH images. Astrocyte numerical densities are region specific 
within the hippocampus and vary by a factor of ~2 in the CA1 layer, with the highest   75
density being in the dendritic arbor (stratum lacunosum-moleculare) and the lowest 
being in the cell layer itself (stratum pyramidale) (25). 
 
3.3.2 NADH fluorescence in GFAP-GFP labeled astrocytes 
  Glial fibrillary acidic protein (GFAP) is a type of intermediate filament unique 
to astrocytes – however not staining all astrocytes. Based on co-staining with other 
astrocyte specific molecules Ogata & Kosaka (25) estimated that ~80% of identifiable 
astrocytes in the CA1 are GFAP(+). Furthermore, comparing GFAP stained astrocytes 
to golgi-stains revealed that GFAP poorly stains the rather extensive astrocytic arbor. 
A transgenic strain of mice expressing green fluorescent protein (GFP) under the 
control of a GFAP (26) promoter (Jasckson Labs, Strain: FVB/N-
Tg(GFAPGFP)14Mes/J) enables the identification of astrocytes in living, unfixed 
tissue by their GFP fluorescence. By imaging both the GFP and NADH fluorescence, 
we can characterize the NADH fluorescence of identifiable astrocytes in comparison 
to the surrounding neuropil. Figure (3.16) shows the GFP fluorescence within a 
hippocampal slice from a GFAP-GFP transgenic mouse. The astrocyte bodies are 
scattered sparsely throughout the neuropil, with each body having a diffuse ‘halo’ of 
GFP fluorescence around it. This diffuse region represents the fine, sub-resolution 
arbors of the astrocytes. These arbors are known to divide the stratum radiatum into 
domains that overlap only slightly (25).    76
 
Figure 3.16 GFP labeled astrocytes in a transgenic mouse hippocampus. This z-
projection shows GFP labeled astrocytes in the hippocampal CA1-CA3 are sparsely 
scattered and tend to divide the neuropil into regions of influence or domains. Scale 
bar is 50µm.  
 
  Images of both the NADH and GFAP-GFP signal from such a slice reveal that 
astrocytes that are easy or moderately easy to identify by their NADH fluorescence 
and morphology are also revealed by the GFAP-GFP signal (Figs.(3.17A-B,D-E). 
However there are also astrocytes revealed by GFAP-GFP that are indistinguishable 
from the surrounding neuropil by their NADH signal (Fig.(3.17C,F)). It is also clear 
from Figs.(3.17A and B) that while the NADH fluorescence may reveal the bodies and 
proximal processes of astrocytes, the somewhat finer distal processes revealed by the   77
GFAP-GFP image are impossible to distinguish from the surrounding neuropil based 
on the NADH fluorescence. This is likely due to the exceedingly small width of the 
distal processes.     
 
Figure 3.17 Identification of astrocytes by GFAP-GFP and NADH. Images of 
astrocytes using GFAP-GFP fluorescence (top row) and the corresponding NADH 
fluorescence (bottom row, arranged under corresponding GFAP-GFP image). Some 
astrocytes are easy to identify by their NADH fluorescence (D), some are moderately 
difficult (E) and some are very difficult (F). Scale bar is 40µm. 
  
  A fixed tissue slice immunostained with GFAP (astrocytes), cytochrome 
oxidase (mitochondria) and DAPI (nuclei) (7) reveals (via GFAP) that astrocytes have 
fine distal processes (<1µm) that are at the limit of the spatial resolution (Fig.3.18). 
  Recall also that GFAP is not a good indicator of the smallest processes in the 
astrocytic arbor, there is in fact a substantial arbor of fine processes surrounding the 
astrocytic soma that are at or below our spatial resolution (25). This implies that the 
neuropil is a combination of neuronal axo-dentritic network and astrocytic processes 
that cannot be morphologically differentiated by their NADH fluorescence. The 
exception is the astrocytic somata and proximal processes.    78
 
Figure 3.18 Immunostain for GFAP in fixed brain tissue. Immunostain for GFAP 
(green) marks astrocytes, cytochrome oxidase (CO, red) marks mitochondria and 
DAPI (blue) marks nuclei. The GFAP stain reveals very fine astrocytic processes. 
Scale bar is 10µm. 
 
  The average intrinsic fluorescence intensity of astrocytes is somewhat higher 
than the neuropil surrounding it. Fig.(3.19) shows a two-dimensional histogram (or 
scatter density plot) of the pixel intensities of an NADH image the corresponding 
GFAP-GFP image (in this case Fig.(3.17A)).  
  There is a clear correlation between GFAP-GFP and NADH intensity. Pixels 
with a high GFAP-GFP intensity (astrocytes) have a more intense NADH intensity. 
However, the distributions of NADH intensity associated with low and high GFAP-
GFP intensities are wide and overlap significantly. This is a reflection of the fact that 
high GFAP-GFP regions (astrocytes) have a high NADH intensity in the cell bodies/ 
proximal processes and a lower NADH intensity in the distal processes. Very low 
GFAP-GFP intensity pixels (neuropil) contain both mitochondria and cytosol – giving 
high and low NADH intensity respectively.   79
 
Figure 3.19 NADH fluorescence versus GFAP-GFAP fluorescence around a 
typical astrocyte. While this 2D histogram (or scatter density plot) reveals a definite 
correlation between GFAP-GFP and NADH intensity around an astrocyte, this 
correlation is loose due to distal astrocytic processes with low NADH intensity. 
    
  In summary, astrocyte cell bodies and proximal processes can be identified by 
their morphology and elevated NADH intensity. The surrounding neuropil however 
contains distal astrocytic processes that are at or below our spatial resolution and that 
cannot be distinguished from the surrounding neuropil. 
 
3.4 Conclusions 
  Biological tissues contain a number of intrinsic fluorophores. It is possible to 
select an excitation wavelength and emission filter to selectively excite and detect 
NADH. Under these conditions, pharmacological, morphological and spectroscopic 
evidence identifies the intrinsic fluorescence from the hippocampal brain slice as   80
predominately NADH. This intrinsic fluorescence does potentially contain 
contaminating signals from NADPH and retinoids that cannot be spectrally excluded. 
These molecules however are not only present at much lower concentrations than 
NADH, but they also represent a largely metabolically inert background that does not 
significantly contribute to metabolism linked fluorescence changes. 
  The morphology of the intrinsic fluorescence in the hippocampus allows a 
clear, unambiguous recognition of neuronal and astrocytic somata and proximal 
processes. The bright, small, roughly circular spots present throughout the 
hippocampus in varying densities are shown by Rh123 stains to be largely 
mitochondria. Furthermore, GFAP-GFP images reveal that astrocytes in the neuropil 
also have a high NADH fluorescence in their bodies and proximal processes. While 
the bright mitochondrial and astrocytic fluorescence is comparable in intensity, these 
compartments are easily distinguished by their morphology. On the other hand, the 
dim distal processes of astrocytes are sub-resolution and cannot be distinguished from 
the surrounding neuropil. With the fluorescence and morphological characteristics of 
these cellular and sub-cellular compartments in mind, we are in a good position to 
begin imaging neuro-metabolic dynamics in response to metabolic effectors.    
         81
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Chapter Four 
Imaging In Vivo NADH Dynamics 
 
 
4.1 Motion correction 
Two-photon fluorescence microscopy offers a high spatial resolution in both 
the axial and lateral directions. Imaging with this resolution offers the opportunity to 
study NADH dynamics in sub-cellular compartments that are not accessible in living 
tissue with other fluorescence techniques. The NADH response in tissue to a particular 
influence e.g metabolic inhibition or metabolic load, is measured by acquiring a time 
series of fluorescence images during which that influence is brought to bear. 
Monitoring the spatial heterogeneity of the response of the tissue is then simply a 
matter of monitoring the intensity change of each pixel separately.  
However, following the intensity of a particular pixel through the time series, 
and interpreting the intensity change in a biologically meaningful way assumes that 
pixel corresponds to the same region of the tissue in each time frame. This is not true 
if the position of the tissue changes between subsequent images. For example pixel 
(100,100) may correspond to a mitochondrion in one image, and in the next image 
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correspond to a cytosolic region due to physical motion of the slice. In this case, the 
change in the intensity of pixel (100,100) is misleading, as it is simply an artifact of 
motion and not a genuine change in the NADH level of a sub-cellular compartment. 
Clearly it is desirable to do a pixel-by-pixel analysis of an image time series as this 
takes advantage of the spatial resolution of TPM to resolve differences in the 
responses of different tissue regions. Doing so however requires a means to correct for 
the motion of the sample.  
Motion elimination is a two step process. The first step is hardware based: 
brain slices in perfusion chambers are usually suspended between nylon meshes, as 
has been previously discussed in Section (2.5.3). While these meshes prevent large 
motions of the tissue, small jitters and drifts are inevitable due to turbulence in the 
perfusate flowing through the chamber. The second step is a software based correction 
for small jitters and drifts of the slice that is applied as part of the post-processing. The 
software correction is presented below. 
 
4.1.1 Strategy for motion correction 
  The general algorithm for motion correction is outlined in Figure (4.1). 
Consider a sequence of N images (I(r,t), t=1 to N) of an object that is moving such 
that its motion between any two given images is small (∆x, ∆y ≤ 10 pixels), and its 
total range of motion is smaller than the total x-y size of an image. The process of 
correcting for its motion begins by considering each sequential pair of images, I(r,n) 
and I(r,n+1). I(r,n+1) is offset in the x and y directions (I(r,n+1) Æ I(r+∆r,n+1)) until 
its similarity to I(r,n) is maximized. The similarity of two images can be measured in a 
number of different ways, and these will be considered in the next section. The offset 
that maximizes similarity is known as the shift vector (∆rn+1,n) for that pair of images 
and gives us the number of pixels in x and y that the sample has shifted between image   85
n and image n+1. Correcting for this shift simply involves offsetting image n+1 by the 
negative of the shift vector. By correcting each image with respect to the one 
preceding it, we can motion correct the entire image series.     
 
 
Figure 4.1 Strategy for motion correction. Motion correction is done by a pairwise 
comparison of images in the time series. Each sequential pair is relatively shifted by 
some ‘shift vector’ until the similarity is maximized.  
 
4.1.2 Measures of image similarity 
  The similarity between two successive images in a series can be measured with 
a number of quantities. We used the linear correlation coefficient, the chi-squared and 
the overlap integral as parameters of varying robustness and computational 
complexity. One of the most common parameters used to measure image similarity is 
the correlation coefficient (Eqn.(4.1)).   86
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  This function has higher values for more correlated images, with a maximum 
value of 1 for identical images, hence maximizing similarity entails maximizing the 
correlation coefficient. While this is a robust measure of similarity, correcting the 
relative offset of two images using this measure was found to take a long time due to 
the complexity of the calculation. For example, a typical pair of 200x200 pixel 
images, required more than 10s to motion correct.  
  Another parameter to estimate similarity that is somewhat simpler in the 
number of separate calculations required, is the chi-squared, defined by Eqn.(4.2). 
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The chi-squared, as usual, requires minimization to give maximum similarity. This 
parameter required some degree of thresholding to be effective for motion correction, 
i.e. very low intensity pixels were not included in the calculation of the parameter 
since they exhibit large fractional changes in their intensity (shot noise). However, 
only the ~20% lowest intensity pixels needed to be excluded, and adjusting the 
threshold beyond that had little effect. The chi-squared, being computationally more 
simple than the correlation, required only ~5s to correct a 200x200 pixel image pair 
for motion. 
  The final parameter – the overlap integral – is the least computationally 
complex parameter and therefore is the fastest to execute. There are objects in a brain   87
slice such as astrocytes, astrocytic mitochondria and blood vessels that are always 
bright (with respect to the average of the slice) regardless of the metabolic condition 
of the surrounding slice. The overlap integral method uses a threshold to isolate these 
bright structures and uses them as landmarks whose motion is an indicator of the 
motion of the slice. This protocol is illustrated in Fig.(4.2) on a typical pair of images 
from a time series.  
 
 
Figure 4.2 Pairwise calculation of relative shift vector. A pair of consecutive 
images (top row) are thresholded to generate binary masks (second row, red = 1, 
blue=0). The overlap integral (bottom row) of the masks is calculated as a function of 
x shift and y shift, and its maximum is taken as the shift vector ∆r.   88
  For both images I(r,t) and I(r,t+1), threshold masks M(r,t) and M(r,t+1) are 
generated. The threshold mask is an array of size equal to the image. Each pixel of the 
threshold mask has a value depending on the value of the corresponding pixel of the 
image. If the image pixel value is greater than the specified threshold (T), then the 
corresponding mask pixel is set to 1, otherwise it is set to 0. That is: M(r,t) =1 if I(r,t) 
> T, M(r,t) = 0 if  I(r,t) ≤ T. The threshold for each image is chosen so that only the 
most intense pixels (~1-5% of the total pixel number) are represented in the mask.  
  Once the masks are generated, these masks are used in place of the images to 
do the maximization of similarity and thereby get the shift vectors. Since the masks 
are logical arrays of 1s and 0s, we can define a simple overlap integral (Eqn.(4.3)) to 
measure their similarity. The overlap integral essentially counts the number of 1s that 
overlap between the two masks. 
 
 
() (,) (, 1 )
or
() (,) (, 1 )
(  is the AND operator)
xy
xy
O t Mt Mt
O t MtMt
= ⋅+
= ∧+
∧
∑∑
∑∑
rr
rr
     (4.3) 
This process is a simple threshold discrimination followed by an AND operation and 
an integration, and is therefore not only the fastest means of motion correction 
considered here (time per pair ~3s) but is also potentially easily adapted to real-time 
motion correction as level discrimination, logical operations and integration are very 
rapidly executed by hardware. It should be noted that all the process times quoted here 
are specific to program execution in Matlab, and are expected to be substantially 
shorter if compiled into an executable program.   89
  Since the overlap integral method actually uses the threshold masks to get the 
shift vectors, its efficacy is very sensitive to the threshold level and structure of the 
image. This method provides the best results when there are obvious small, bright 
regions in the tissue – which is the case for most high resolution brain slice images. 
When a high intensity threshold is applied to such an image, the result is a sparse field 
of small spots which are easily tracked from one image to the next. Images which are 
more homogenous in appearance (e.g. low magnification, or low resolution) are better 
dealt with using the chi-squared method. However, given the structure of brain tissue, 
the overlap integral is our method of choice for motion correction in high resolution 
image series. 
 
Table 4.1 Summary of measures of image similarity. 
 
 
4.1.3 Extrapolating motion correction from an image pair to an image series 
  Motion correction is done only between two sequential images, as opposed to 
correcting each image with respect to a baseline image early in the time series. We do 
this as images later on in the time series may have undergone significant physiological 
changes as a result of metabolic manipulations during the time series. Because of these   90
changes, a late image may be sufficiently different from an early one that it is difficult 
to compare them to get an exact measure of the relative shift. In contrast, there are 
usually only slight changes between sequential images, and hence they can more 
readily be compared to correct for motion between them. 
  The shift vector (∆r) for every sequential image pair in the series provides the 
position of every image with respect to its immediate predecessor. Hence the position 
of image n (rn) with respect to the first image (taken as (0,0)) is the cumulative sum of 
shift vectors up to that image (Eqn.(4.4)). 
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Each image is then moved by the negative of its position vector with respect to the 
first image. In effect, this is tantamount to transferring the motion of the specimen to 
the motion of the frame; causing the physical structures in the specimen to remain in 
the same place while the frame moves around.   
 
4.1.4 Reduction of motion artifact 
  While the overlap integral is a fast and practical means of motion correction, 
we return to the more robust correlation coefficient to study the effect of motion and 
motion correction as a function of the time difference between images (∆T; expressed 
as frames, each frame = 5-60s depending on the experiment). In general, for a motion 
corrected sample, the amplitude of the correlation decay (at ∆T=1) is a function of 
spontaneous intensity fluctuations (shot noise). Since there is little motion between 
immediately successive images, variations in pixel intensities are dominated by noise, 
which is reflected in the initial amplitude of the correlation decay. On the other hand, 
if each pixel only randomly fluctuated about its own constant mean value, then the   91
correlation would not decay with time. The decay of the correlation is due to residual 
motion (x,y and z) of the sample that could not be corrected for, and represents a 
limiting factor on the length of a time for which a given pixel can be said to be 
monitoring the same physical structure.  
  A typical uncorrected time series shows a correlation coefficient that drops 
rapidly from a peak value of ~0.68 to ~0.3 within 12 frames (Fig.(4.3a), blue). After 
motion correction (red curve), the correlation has a higher peak value (0.75) and drops 
much more slowly, leveling off at a value of ~0.55 after 17 frames. The slower decay 
indicates that significant overlap between images is maintained for much longer than 
in the uncorrected time series.  
  The motion correction in this case was done using the overlap integral method. 
Instead, if we use the chi-squared method, we obtain a correlation decay which is 
virtually identical to that obtained with the overlap integral method (Fig.(4.3b)). 
Hence we see that using the chi-squared parameter to quantify image similarity does 
not necessarily yield a better motion correction and takes more time to do the 
correction.  
  The overall amplitude of the correlation is reduced by spontaneous temporal 
fluctuations in pixel intensities (shot noise). These fluctuations can be reduced by 
smoothing each pixel with a temporal Gaussian 3 filter – which performs a weighted 
average of the value of each pixel in an image with its value in the image immediately 
prior and immediately following the image. It is important that motion correction be 
done prior to temporal smoothing, since before motion correction, the same pixel in 
sequential images can correspond to different physical structures. Temporal smoothing 
reduces shot noise and therefore shifts the entire correlation decay curve up (Fig.4.3c), 
yielding a peak value of ~0.93 (recall the theoretical maximum is 1). This exceedingly   92
high correlation for ∆T=1 indicates that immediately sequential images are, on 
average, essentially identical. 
 
Figure 4.3 Correlation decays show motion correction reduces motion artifact. 
(A) Image series temporal correlation decay before motion correction (blue) and after 
(red). (B) The post-correction correlation is not greatly affected by the choice of image 
similarity parameter. (C) Temporal smoothing increases the correlation amplitude but 
not the decay time. (D) Spatial autocorrelation reveals the spatial shift corresponding 
to a particular value of correlation. 
  
  To understand the effect of motion on the correlation decay, we correlate an 
image with itself offset by a certain number of pixels – a spatial auto-correlation. 
Fig.(4.3d) shows the averaged spatial auto-correlations for all the images in the time 
series being considered in this case study. Since an auto-correlation correlates each 
image with itself, there are no changes in pixel intensity due to shot noise and 
therefore the correlation amplitude at zero relative offset is unity and the decay is   93
strictly due to spatial offset. In contrast, sequential images, even if perfectly motion 
corrected still exhibit shot noise and hence do not give unit correlation amplitude at 
zero relative offset. The auto-correlation is observed to decay rapidly within only a 
few pixels of relative offset. We know that mitochondria are on the order of 1-2 
microns in width, and hence we would like to restrict our pixel-by-pixel analysis of 
time series to sections that have less than 0.5-1 micron of motion. In this particular 
image series, the pixel size is about 0.43 microns, hence a motion of 1.5 microns (a 
mitochondrion) corresponds to ~3.5 pixels. We would like to restrict our consideration 
to image series that have less than half that motion, i.e. 1.7 pixels, which corresponds 
to a decrease in the correlation of ~0.75 from Fig.(4.3d). From Fig.(4.3c) we see that 
the correlation is greater than 0.75 up to about ∆T=6, implying that we can take 
sections of the image series up to 7 (∆T +1) frames long and expect that they are 
correlated to better than half a mitochondrion worth of motion.   
      
4.1.5 Post motion correction artifact in intensity based region of interest 
selection: difference-intensity anti-correlation 
  Once motion correction is done, it is possible to follow the intensity changes in 
pixel sub-populations of the image, known as regions of interest (ROIs). Assigning 
physical significance to intensity changes assumes that their baseline changes are zero 
on average. However, if we calculate the pixel-by-pixel difference between a typical 
consecutive image pair (D(x,y,t) = I(x,y,t+1) – I(x,y,t)) that are part of the baseline 
phase of the time series, we find that while the average difference (<D(x,y,t)>) is in 
fact approximately zero, a scatter plot of the difference versus the initial intensity 
(Fig.(4.4a)) reveals a negative correlation between the two. Low intensity pixels tend 
to increase in intensity while high intensity pixels tend to decrease in intensity.   94
Averaging the differences over ranges of initial intensities (Fig.(4.4b)) better 
elucidates this difference-intensity anti-correlation.   
 
Figure 4.4 Difference-intensity anti-correlation. (A) Scatter plot of the initial 
intensities of baseline phase pixels versus their intensity changes. (B) Averaging the 
scatter in (A) into intensity bins elucidates the dependence. (C) The intensity 
histogram of the initial image which gave rise to the spontaneous changes plotted in 
(A and B). 
 
  This particular effect is a consequence of the shape of the intensity histogram 
of the image. When pixels of a specific intensity range – call this the i
th intensity bin - 
are selected in an image, there are actually three populations of pixels that are 
selected:  
1. ni pixels with a mean intensity within the i
th intensity bin whose current value also 
lies within the i
th bin.    95
2. ni+1 pixels with a mean intensity in the next higher (i+1)
th bin but whose intensity at 
this time point happens to lie in the i
th bin due to spontaneous fluctuations. 
3. ni-1 pixels with a mean intensity in the next lower bin (i-1)
th bin but whose intensity 
at this time point happens to lie in the i
th bin due to spontaneous fluctuations.      
The integrated intensity of the selected pixels at time t is then: 
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In the next time frame (t+1), those ni pixels with a mean intensity in the i
th bin will on 
average have an intensity Ii. Those ni+1 pixels that were selected during a spontaneous 
downward fluctuation will now, on average, fluctuate upwards to their mean intensity 
of Ii+1. Similarly, those ni-1 pixels that were selected during a spontaneous upward 
fluctuation will now, on average, have an intensity of Ii-1. The integrated intensity of 
the selected pixels is then: 
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The change in the integrated intensity of the selected pixels is: 
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Here ∆I is the inter-bin intensity interval, and we assume that ni±1 are proportional to 
the total pixel populations of the respective bins Ni±1 with c being the constant of 
proportionality. The shape of the image intensity histogram (Fig.(4.4c)) is such that for 
low intensities, the histogram has a positive slope up to the intensity of the histogram   96
peak (Ipeak). For intensities higher than Ipeak, the slope of the histogram is negative. In 
other words: 
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At the peak of the histogram, Ni+1 = Ni-1 and the difference should be zero. This 
behavior is seen in Fig.(4.4c) where the difference is positive for low intensities, 
decreases to zero at the intensity of the histogram peak, and becomes negative for 
higher intensities. 
  Since the cause of this effect is the spontaneous fluctuation of pixel intensities, 
reducing fluctuations by applying spatio-temporal smoothing filters should reduce the 
effect. A number of Gaussian spatio-temporal filters were tried. These filters have 
binning factors given by [nx ny nt], e.g. [3 3 1] refers to a 3x3 spatial filtering with no 
temporal filtering. The result of applying these filters on the difference versus intensity 
curve is shown in Fig.(4.5a). The Gaussian [1 1 3] filter – a Gaussian 3 temporal 
smoothing is highly effective and entails no spatial filtering which reduces spatial 
resolution and is therefore the smoothing we apply for subsequent analysis. 
  The difference-intensity anti-correlation effect can also be reduced by 
increasing the width of the intensity bins, or equivalently, reducing the total number of 
intensity bins. Increasing the intensity bin width reduces the probability that a pixel 
will fluctuate out of its intensity bin. Unfortunately, increasing bin width compromises 
the ability to measure differences in the responses of different intensities. As 
Fig.(4.5b) shows, drastically reducing the total number of intensity bins to 2 is less   97
effective than a simple Gaussian 3 temporal filter. For a more reasonable number of 
bins (5-10), there is little advantage obtained by using fewer bins and hence we do not 
rely on the number of bins, but rather the smoothing filters to reduce the difference-
intensity anti-correlation effect. In practice, we use 5-10 intensity bins. 
             
 
Figure 4.5 Methods of reducing intensity dependent spontaneous intensity 
changes. (A) Applying Gaussian spatial filters of dimensionality [nx ny nt] smoothes 
out noise and reduces the magnitude of the intensity dependent intensity change. (B) 
Alternatively, grouping pixels into of intensity range bins also reduces the artifact.    
 
4.1.6 Limitations of the motion correction protocol 
  This motion correction program works only for simple x-y linear shifts of the 
sample. Motions that it cannot accommodate for are: rotation, distortion, z-drift, and 
morphological alteration. Usually however, for tissue that either rotates or distorts, the 
tissue image can be divided into smaller regions whose motion can be approximated as 
linear shifts. In this case, we can consider small regions of the tissue separately and 
apply this motion correction program to those regions as if they were independent 
images series. Z-drift correction is not possible at all with this program. In theory, the 
program could be trivially extended to correct for motion in the z direction – however 
it would entail acquiring a time series of x-y-z images. This is not currently done in   98
our experiments. Lastly, it is also possible that genuine morphological changes occur 
in the tissue during a time series acquisition. Specifically, mitochondria are known to 
be mobile. This motion is slow and imaging experiments over the course of a few 
minutes can neglect this motion. Hypoxia experiments however can take 20-30 
minutes. During this time it is possible for the mitochondrial distribution to change 
slightly. This mobility of fluorescent mitochondria represents a changing fluorescence 
distribution that cannot be corrected. Typically, we deal with this problem by either 
limiting pixel-by-pixel analyses to time intervals of a couple of minutes, or by 
measuring average intensity characteristics of large populations of pixels. 
 
4.2 NADH response to hypoxia induced metabolic inhibition 
  The motion correction protocol presented in the previous section enables us to 
track tissue intrinsic fluorescence changes on a pixel-by-pixel basis. We now apply 
this analysis protocol to real time courses of two types of functional fluorescence 
responses: the response to metabolic inhibition (hypoxia) and to metabolic load 
(electrical activity). Using the ability of the pixel-by-pixel analysis to resolve fine 
spatio-temporal heterogeneity in tissue metabolic response, we will demonstrate 
differences in the metabolic response of cytosol and mitochondria to hypoxia, and 
neurons and cytosol to electrical stimulation. We begin with the response of resting 
neurons to metabolic inhibition.  
 
4.2.1 Energy metabolism in resting neurons  
  The current picture of neuronal metabolism postulates that neurons use 
oxidative metabolism simply to maintain basal metabolic processes (1,2). There is 
some controversy regarding the source of the additional energy required by activate 
neurons. In particular, the balance of anaerobic glycolysis and aerobic oxidative   99
phosphorylation in fueling neural activity is somewhat controversial.  We have 
contributed evidence towards a resolution of that controversy which will be discussed 
later in Section (4.3)(3). 
  Resting neurons use the largest part of their ATP to maintain resting membrane 
potential (4). Of the ion pumps involved in maintaining ion homeostasis, the Na-K-
ATPase consumes the majority (>50%) of cellular ATP. The Na-K-ATPase pump 
works incessantly to pump K
+ ions into the neuron and Na
+ ions out of the neuron in 
order to compensate for their leak across the plasma membrane. While the Na-K-
ATPase pump is the dominant pump for maintaining membrane potential, there are 
other ion pumps in the neuronal membrane. However, these are either passive 
transport pumps, produce a relatively small demand on oxidative metabolism, or begin 
functioning only during (or shortly after) an action potential, i.e. in an active neuron 
(4). This dependence of the basic membrane integrity of the neuron on aerobically 
derived energy makes neurons acutely sensitive to oxygen deprivation. 
 
4.2.2 Effects of hypoxia  
  Transient hypoxia followed by reperfusion triggers changes in metabolite 
concentrations, ion gradients, and protein expression that can lead to both long term 
damage and protection against further hypoxic insults. Some of these changes occur 
rapidly, on the time scale of our experiments, while others such as changes in protein 
expression can take many hours or more. We will confine our discussion here to those 
changes that occur on the time scale of our experiments and that are relevant to the 
immediate metabolic state. 
  The most direct effect of removing oxygen from the intracellular environment 
is the inhibition of mitochondrial metabolism (see Section (2.1)). Without active 
mitochondria, which are the most efficient source of ATP, the ATP level in the cell   100
drops precipitously and ADP begins to accumulate (5-8). ADP upregulates glycolytic 
enzymes, representing an attempt to make up the ATP shortfall through anaerobic 
metabolism. Glycolysis however is a poor source of ATP and is unable to sustain the 
normal activity of the Na-K-ATPase, which leads to an almost complete 
depolarization of the plasma membrane (9). Within ~5 minutes of the onset of anoxia, 
intracellular Na
+ increases by a factor of ~2 (10) and extracellular K
+ increases by a 
factor of ~1.4-2 (11). 
  It is believed that the increased intracellular Na
+ concentration caused by the 
failure of the Na-K-ATPase pump leads to the activation of the Na-Ca antiporter in the 
plasma membrane. As Na
+ leaks into the cytosol, this pump begins to shuttle 2Na
+ 
back out of the cytosol in exchange for Ca
2+ from the extracellular medium. In this 
way, there is a Ca
2+ build up in the neuron (12). The elevated intracellular Ca
2+ level 
has a profound influence on many processes. In particular, Ca
2+ is known to 
upregulate the activity of metabolic enzymes in the mitochondria (see Section (2.1)). 
During hypoxia, this has little effect as there is no oxygen to allow the electron 
transport chain to run. However, upon post-hypoxic reperfusion with normoxic ACSF, 
the cell is faced with elevated levels of ADP, NADH, Ca
2+ and a normal level of 
oxygen. The result is that the flux through the mitochondrial metabolic pathways is 
higher than normal, bringing the NADH level not simply back to baseline, but in fact 
causing a hyperoxidation of mitochondrial NADH (13-15).  
  In oxidative metabolism, pyruvate produced during glycolysis ultimately 
serves as the initial substrate for mitochondrial metabolism. When the cell switches to 
anaerobic glycolysis, pyruvate can no longer be used by mitochondria. To prevent 
product inhibition of glycolysis, this pyruvate is converted into lactate (lactic acid). 
Tissue lactate rises from ~4mM (16) to 8-15mM (16-18) during hypoxia. This lactate 
build up is largely responsible for the fall of the intracellular pH from ~7.4 (19-21) to   101
~6.5-6.7 after 10 min hypoxia (20). While an excessive accumulation of lactate can 
cause damage due to the decreased pH, the amount accumulated during brief hypoxic 
intervals plays an important role in the post-hypoxic recovery of normal synaptic 
activity. Accumulated extracellular lactate is used as the principal source of energy 
during post-hypoxic recovery, rather than glucose, and is responsible for restoring 
~80% of synaptic activity (22,23).  
 
4.2.3 Analysis of hypoxia image time series  
4.2.3.1 Structure of time series 
  A time series consists of a sequence of N images acquired with an inter-image 
interval ∆t. Throughout the time series, the sample is being constantly perfused with 
artificial cerebro-spinal fluid, and the metabolic state of the slice is controlled by the 
oxygen concentration of this perfusate. For studies of metabolic dynamics in 
hippocampal brain slices, the time series has three phases: 
 
1. Baseline: This is a series of 10 images taken 30 seconds apart, acquired while the 
slice is maintained in its normal, resting state. The surrounding perfusate has a high 
partial pressure of oxygen (0.6-0.8 atm depending on perfusion chamber). The purpose 
of this series is to record the spatial distribution and spontaneous intensity fluctuations 
(noise) of the intrinsic fluorescence in an unperturbed, resting metabolic state.  
 
2. Response (or Early Response): During this middle phase of 10 images, the perfusate 
is switched to a solution with no oxygen, leading to metabolic inhibition. The time 
scale of the change in oxygen concentration in the actual perfusion chamber depends 
on the geometry and flow speed. In the open perfusion chambers, oxygen level reaches 
a minimum in ~ 2 minutes and in the fast flow closed chambers, this takes <10   102
seconds. The effect of this metabolic perturbation on the intrinsic fluorescence is 
imaged for another 10 images, allowing the response to complete and the fluorescence 
to stabilize at some new value. 
 
3. Recovery (or Late Response): During this last phase of 15 images, the external 
conditions are returned to their normal, baseline values, i.e. the high oxygen perfusate 
is returned to the chamber. The tissue is then imaged as it recovers and re-establishes 
its baseline metabolic state. While this phase consists of 15 images in our experiments, 
we will show later that this duration was ultimately insufficient for the tissue to 
recover all of its baseline fluorescence characteristics. 
 
4.2.3.2 Motion correction and sub-series definition 
  Each image in the slice was first smoothed with a Gaussian 3x3 spatial filter in 
order to reduce noise. After smoothing, motion correction of the slice was done 
according to the protocol described in Section (4.1). Typically, using only the brightest 
1% of all pixels for motion correction, and splitting the image into 100x100 to 
200x200 pixel sub-images was found to be most effective in eliminating motion. After 
motion correction, a further Gaussian 3 temporal filter was applied to reduce post-
motion correction difference intensity anti-correlation (see Section (4.1)).  
  The temporal correlation curve for each image series (r(t)) was calculated to 
yield a measure of the residual uncorrectable motion of the sample (see Section (4.1)). 
This determined how far a given region of interest could be followed in time before 
the correlation decay indicated that an unacceptable amount of motion had 
accumulated. In all cases, we defined an unacceptable amount of motion as >0.75 
micron – chosen as it corresponds to about half the width of a mitochondria. Based on 
this criterion, in a typical image series of 35 images (10 baseline + 10 response + 15   103
recovery), a given region of interest could only be followed for ~4-7 images. 
Nonetheless, many of the interesting changes that occur in hypoxia response and 
recovery occur within about 3-4 image frames. Hence by selecting sub-series of 4-7 
images at critical time points within the main image series, it is still possible to 
perform pixel-by-pixel measurements on interesting metabolic dynamics. 
  There are four time sub-series that we define for the purpose of pixel-by-pixel 
analysis which correspond to physiologically distinct events. The time intervals 
bounding these four sub-series are shown in Figure (4.6) on a plot of the mean 
fluorescence intensity.  
 
 
Figure 4.6 Mean intensity of intrinsic fluorescence during transient hypoxia. The 
phases indicated by the vertical lines are: normoxia-hypoxia transition (black), 
sustained hypoxia (red), hypoxia-normoxia transition (green), post-hypoxic recovery 
(blue).  
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These sub-series intervals are: 
Normoxia to Hypoxia Transition. 
Sustained Hypoxia 
Hypoxia to Normoxia Transition 
Post-hypoxic Recovery     
 
4.2.3.3 Intensity changes of percentile bins 
  Figure (4.7a) shows the intensity histograms of a series of images before, 
during and after a brief hypoxic episode. Note that during hypoxia, the histogram 
decreases in height, increases in width and moves higher up the intensity axis. The 
intensity increase and spreading of the histogram implies that pixels of a higher 
intensity undergo a greater absolute intensity increase than those of a lower intensity.  
  Considering the histograms of the images normalized by their respective mean 
intensities (Fig.(4.7b,c)) however reveals that the shapes of the histograms during all 
three metabolic states are very similar. This behavior suggests that pixels largely 
maintain their intensity percentile rankings during hypoxia and reperfusion. 
Significant populations of pixels changing their percentile ranking would cause the 
shape of the histogram to change i.e. narrow. 
  Since the intensity percentile of a pixel does not change, on average, during a 
time series, it follows that a given range of intensity percentiles represents the same 
population of pixels throughout the time series. It is therefore reasonable to use a 
percentile range to define populations of pixels in each image. A given percentile 
range represents the same set of pixels throughout the time series, and we can 
therefore measure the average intensity of that percentile range as a function of time to 
arrive at the intensity response of different sets of pixels with different average 
baseline intensities.   105
 
Figure 4.7 Intensity histograms of intrinsic fluorescence during transient 
hypoxia. (A) Intensity histogram of brain slice before, during and after hypoxia. (B) 
Intensity histograms of normoxic and hypoxic tissue normalized by their respective 
mean intensities. (C) Intensity histogram of normoxic and recovered tissue normalized 
by their respective mean intensities. 
 
  Furthermore, given the large difference in NADH fluorescence intensity 
between mitochondria and cytosol observed in cultured cells (see Section (3.2.1)), it is 
reasonable to expect a similar correspondence in tissue. It is therefore of particular 
interest to compare the responses of the highest and lowest intensity pixels. The 
average intensity of 5 percentile ranges (0-20%, 20-40%, 40-60%, 60-80%, 80-100%) 
is calculated as a function of time. The number of percentile bins was chosen as a 
compromise between reducing difference-intensity anti-correlation (see Section 
(4.1.5)) and still being able to discriminate high and low intensity pixels. The resulting   106
calculated responses of the highest and lowest intensity bins during the image intervals 
defined above (Section 4.2.3.2) are shown below in Figure (4.8).  
 
 
Figure 4.8 Response of the brightest and dimmest pixels to hypoxia. The motion 
corrected sub-series of the hypoxic response - defined by colored intervals in the top 
graph – were analyzed individually. The responses of the lowest 20
th percentile (blue 
curve) and highest 20
th percentile (red curve) during these intervals are plotted in the 
lower graph. The responses are pasted together for convenience of display. 
 
  During the normoxia to hypoxia transition (black interval) both intensity 
brackets respond similarly, with a slightly greater fractional increase in the lower 
intensity bracket. The higher intensity bracket stops increasing shortly after the   107
normoxia to hypoxia transition while the low intensity pixels continue to increase in 
intensity during the sustained hypoxia sub-series (red interval). Upon reperfusion, both 
intensity brackets decrease in intensity with a slightly greater fractional decrease in the 
high intensity bracket (green interval). During post-hypoxic recovery (blue interval), 
the low intensity bracket undergoes a slight continued decrease while the high 
intensity pixels continue to decrease in intensity very substantially. 
 
4.2.3.4 Discussion of heterogeneous response to hypoxia 
  The observed heterogeneous response to hypoxia is consistent with the 
interpretation that the highest intensity pixels are predominately mitochondrial, while 
the lowest intensity pixels are predominately cytosolic. Hypoxia leads to a build up of 
cytosolic and mitochondrial ADP, Ca
2+ and NADH (Section (4.2.2)). While all these 
factors would normally increase flux through the electron transport chain (ETC), the 
lack of oxygen does not allow the ETC to run faster. When the oxygen is returned to 
baseline levels during reperfusion, the ETC runs at a rate higher than baseline due to 
the built up ADP, Ca
2+ and NADH. This elevated activity of the ETC is sustained, 
thereby producing a hyperoxidation of NADH to below its baseline level. 
  Low intensity pixels are cytosolic in origin. The cytosol is somewhat slower to 
reach its peak response than mitochondria, as seen in the continued rise of the low 
intensity pixels during the sustained hypoxia sub-series while the high intensity pixels 
remain constant. This is understandable given that hypoxia acts directly on 
mitochondria. The cytosolic NADH responds to the increase in mitochondrial NADH. 
Upon hypoxia, ATP must be generated from anaerobic glycolysis. In order to do this, 
glycolitically derived pyruvate in the cytosol, normally destined for mitochondria, is 
instead converted to lactate to prevent product inhibition of glycolysis, leading to a 
build up of lactate in the cytosol/extracellular space. Since the NADH/NAD+ ratio is   108
in rapid equilibrium with the lactate/pyruvate ratio (24), the lactate build up increases 
the NADH level. Upon reperfusion, this accumulated lactate will slow the decrease in 
the cytosolic NADH level as the lactate either diffuses out of the immediate 
extracellular space, or is reconverted into pyruvate for use in mitochondria.  
  
4.2.4 Conclusions 
  Previous work done on intrinsic NADH fluorescence dynamics averages the 
fluorescence signal over a relatively large region of tissue (25-29). This provides no 
information about the spatial heterogeneity of the NADH response to metabolic 
inhibition. While two-photon microscopy provides adequate resolution to detect 
spatial heterogeneity on the length scale of metabolic compartmentation, pixel-by-
pixel analysis is difficult due to sample motion. Motion correction provides the ability 
to discriminate and separately follow high and low intensity pixels which in turn 
allows the dissection of the mitochondrial and cytosolic response to hypoxia.  
  We find that pixels identified as mitochondria exhibit a rapid increase in 
intensity upon hypoxia and undergo a post-hypoxic hyperoxidation. In contrast pixels 
identified as cytosolic respond more slowly to hypoxia and incompletely recover on 
the time scale of our experiments. These results are consistent with the known 
hypoxic/ischemic response of NADH in isolated mitochondria and extracellular lactate 
in intact brain tissue. This demonstrates that pixel-by-pixel analysis of motion 
corrected 2P NADH fluorescence images can probe metabolic response heterogeneity 
in intact neural tissue. The ability to follow the time evolution of pixels will be applied 
in the next section to explore the controversial partitioning of activity induced 
metabolic load between neurons and astrocytes.   
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4.3 NADH response to activity induced metabolic load 
4.3.1 Energy metabolism in active neurons 
  The prevailing view of metabolism in neurons in resting state (see previous 
Section) is largely agreed upon. In stark contrast, considerable controversy has 
surrounded the picture of metabolic dynamics in active neurons. Much of this 
controversy is due to the limitations of the various metabolic imaging techniques 
(fMRI, PET, optical spectroscopy) that have provided different and at times discordant 
pieces of the puzzle. Some of the most prolific contributors are techniques (fMRI, 
optical spectroscopy) whose relations to fundamental cellular mechanisms are not 
quantitatively understood.   
  The controversy surrounds the source of the additional energy used by active 
neurons. Fox et al (30) used PET to show that neural activity induces a transient 
glucose uptake in excess of the glucose actually consumed by oxidative metabolism – 
arguing for an increase in anaerobic glycolysis during activity. In contrast, evidence 
from NMR(31) and optical spectroscopy (32) suggests oxidative metabolism is the 
principal energy source for neural activity. Continued investigation of this controversy 
has lead to the hypothesis that perhaps the partitioning of the metabolic cost of activity 
between astrocytes and neurons underlies the apparent disparities between these 
experimental results.  
  Pellerin & Magistretti showed that glutamate uptake by astrocytes in culture 
stimulates them to release lactate (33). Furthermore, lactate can serve in place of 
glucose as a substrate for active neurons (34,35). This evidence led Pellerin & 
Magistretti to propose what is now known as the lactate shuttle hypothesis (36) which 
postulates that astrocytes exhibit aerobic glycolysis, i.e. they convert glucose 
predominately into lactate, which is then transferred through the extracellular space to 
neurons and converted into pyruvate for oxidative metabolism. However, there was no   110
direct evidence for this specific interplay of astrocytes and neurons during neural 
activity.  
  The need to monitor rapid metabolic responses to electrical activity with 
sufficient spatial resolution to distinguish astrocytes and neurons was stated by a 
number of investigators (35,37-41). The techniques mentioned above (fMRI, PET, 
spectroscopy) however fall far short of the required spatial resolution (~1-10µm). This 
represents an ideal opportunity for multi-photon microscopy, which we have shown in 
previous chapters to have adequate spatial resolution to distinguish neurons versus 
astrocytes and even mitochondrial versus glycolytic compartments. The experiments 
and analysis presented here were done by Kasischke et al (3) and provided the first 
direct support for the lactate shuttle model of neurometabolic coupling.  
 
4.3.2 Stimulation and imaging protocol 
  The stimulation and imaging of brain slices was done in 3 distinct phases 
analogous to the baseline, response and recovery phases of the hypoxia time series in 
the previous section.  
 
1. Baseline – a basal level of activity was maintained by stimulating at 0.2Hz for 5 
minutes during which images were recorded every 60 seconds. The purpose for the 
minimal stimulation is not to induce metabolic load, but rather, to monitor the 
response of the slice to stimulation. In particular, local field potentials (LFPs) that are 
stable and significant in amplitude are required before we can quantitatively study the 
response of the tissue to heightened stimulation. The stability and amplitude of the 
evoked local field potentials are often simply a function of the health of the slice and 
the location of the stimulation and recording electrodes. Brain slices that have not 
recuperated sufficiently from the preparation procedure respond only weakly to   111
stimulation. Typically, a brain slice requires 60-90 minutes to recover from 
preparation. On the other hand, significant LFP amplitude is often a question of 
optimizing the position of the stimulating and recording electrodes so that recording is 
occurring near the subset of the Schaeffer collaterals that are being stimulated. 
 
2. Stimulation Response – the activity induced metabolic load was increased by 
increasing the stimulation frequency to 32Hz. This heightened activity was sustained 
for 5, 20, 60 or 240s during which time images were recorded every 5 seconds.  
 
3. Recovery – the stimulation protocol was returned to that of baseline (i.e. 0.2 Hz) 
and images were recorded every 60 seconds for another 5 minutes while the brain slice 
recovered from the transient elevated load.      
 
4.3.3 Image analysis protocol 
4.3.3.1 Motion correction 
  This was done according to the algorithm detailed in Section (4.1). The 
specifics to these time series follow. Image series were broken up into 150x150 pixel 
regions to accommodate tissue distortion. Motion correction was done using 
maximization of the overlap integral of the brightest 1-2% of pixels. Motion in 
stimulation series is typically not as severe as it is in hypoxia series for a number of 
reasons. Firstly, in order to stimulate and record from the brain slice, electrodes are 
inserted into the tissue, this has the incidental benefit of anchoring the slice down so 
that only slight jitter must be corrected. Secondly, during the stimulation phase of the 
image series, images are acquired every 5 seconds – a much shorter time than the 30-
60 second interval between hypoxia series images – reducing the amount of drift 
between sequential images. Lastly, the physiological changes that occur upon transient   112
metabolic load are much less drastic than those that occur upon hypoxia. Changes in 
average fluorescence (<5%) and tissue distortion due to swelling are comparatively 
small. 
 
4.3.3.2 Criterion for significance of response  
  Perhaps the most significant difference between the analysis of the response to 
stimulation and to hypoxia is that not all points in the tissue will respond to 
stimulation. This simply reflects the fact that synaptic release is a stochastic process 
and hence not all synapses in the imaged region will be activated by stimulation. 
Therefore, to quantify NADH response to neural activity, it is necessary to exclude 
from analysis those pixels that do not respond. For each pixel, the mean and standard 
deviation of the intensity were calculated during intervals in the baseline and response 
phase. If the means were significantly different (p<0.05) then that pixel was deemed to 
have a statistically significant change or response. Only pixels with a significant 
response were included in analysis. 
 
4.3.3.3 Definition of overshoot and dip masks  
  In order to specify which pixels have statistically significant responses upon 
stimulation, we define Overshoot and Dip Masks. Overshoot and Dip Masks are arrays 
that have a 1 at those pixels with statistically significant fluorescence increases and 
decreases respectively, and a 0 at all other pixels. Generating these masks entails first 
calculating the following arrays from the recorded time series I(x,y,t):  
a. Baseline mean array: 
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This is the standard deviation of the fluctuations of each pixel during the baseline 
phase.  
c. The Dip Image:  (,) dip I xy is an average of a range of images around the peak of the 
mean intensity dip (point of lowest mean intensity). This range usually begins 
immediately after the baseline phase at image 5 and extends for ~4 images.  
d. The Overshoot Image:  (,) ovs I xyis an average of a range of images around the peak 
of the mean intensity rise (point of highest mean intensity). This range usually begins 
~2 images after the dip range and can extend as far as the end of the response phase. 
 
The Dip Mask (DM(x,y)), is then the logical array defined by: 
 
(,) 1    i f   (,) (,) (,)
(,) 0   i f   (,) (,) (,)
dip base dip base
dip base dip base
DM x y I x y I x y T x y
D Mxy I xy I xy T xy
σ
σ
=≤ −
=> −
   (4.9) 
Analogously, the Overshoot Mask (OM(x,y)) is the logical array defined by: 
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where  
 
1 (,) dip base dip base dip Tt n nn n
1 − − =+    (4.11) 
Here ndip and nbase are the number of images averaged into the dip and baseline images 
respectively. The parameter t(nbase, ndip) is the t value for a 95% confidence interval 
with (nbase+ ndip-2) degrees of freedom taken from a standard Student’s t table. Tovs is 
defined analogously.    114
  These masks now define those pixels which have a statistically significant dip 
or overshoot, and hence exclude those pixels whose intensity change is due simply to 
spontaneous fluctuation (noise) and not true physiological response. Restricting 
analysis to these pixels enables the extraction of the true microscopic metabolic 
response to activity that is not diminished by averaging with non-responding regions.   
  
 
4.3.3.4 Application of dip and overshoot masks  
  Once the Dip and Overshoot Masks are defined, they are multiplied (pixel-by-
pixel) to any given image or set of images in the time series to restrict analysis to non-
zero pixels. Using the dip and overshoot masks, we can calculate: 
1. The correlation of the dip and overshoot masks. This parameter reveals whether 
regions that significantly dip and overshoot are correlated in their location within the 
tissue. 
2. Baseline intensity histograms of dip and overshoot regions. Applying the Dip and 
Overshoot Masks to the baseline mean image, and histogramming the resulting non-
zero pixels gives us the intensity histograms of those pixels that dip and those that 
overshoot. 
3. Time evolution of the Dip and Overshoot regions. By applying the Dip and 
Overshoot Masks separately to the entire time series, we can follow the time evolution 
of these separate populations of pixels.   
 
4.3.4 Results of analysis 
4.3.4.1 Correlation of the dip and overshoot regions  
  An example of the spatial relationship between the dip regions, overshoot 
regions and underlying NADH intensity is shown in Fig.(4.9). The superposition of   115
the dip and the overshoot masks onto the baseline images revealed that the dip 
originated from small, roughly circular areas (Fig.(4.9c)). In contrast, overshoot 
regions were significantly larger than the dip regions, and often co-localized with 
identifiable astrocyte bodies (Fig.(4.9d)).  Overlaying the dip and overshoot masks 
(Fig.(4.9b)) reveals that there is essentially no overlap between the two.  
 
 
Figure 4.9 Spatial relation of dip, overshoot and NADH. (A) Intrinsic fluorescence 
from neuropil showing bright astrocyte. (B) Dip (green) and overshoot (red) masks 
show little co-localization (yellow). (C) Dip region (green) overlayed on intrinsic 
fluorescence. (D) Overshoot (red) overlayed on intrinsic fluorescence. Scale bar is 
20µm. 
 
  The linear correlation coefficient or Pearson correlation coefficient (r) of the 
dip and overshoot masks is calculated to be r = -0.92±0.02 (N=9), indicating a strong   116
anti-correlation of the two regions. The linear correlation coefficient is a measure of 
the degree of linear correlation between two variables (42). Given two arrays A and B, 
the correlation coefficient is defined as: 
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This is a continuous variable that ranges between –1 for completely anti-correlated 
arrays, to 0 for uncorrelated arrays, to 1 for correlated arrays. In calculating the 
correlation, the sum is over only those pixels that respond to stimulation, i.e. exhibit 
either a dip or an overshoot (or both). Pixels that fail to exhibit significant response to 
stimulation are not included in the sum.The quantity r
2 is also known as the coefficient 
of determination and represents the fraction of the variation between the two arrays 
that can be explained by a linear relationship. Small values of r
2 tend to indicate either 
significant scatter in the data, or a nonlinear relationship between the two variables. 
Given an observed correlation coefficient, r, between two arrays (of N pixels), the 
probability that the magnitude of this correlation arose from uncorrelated arrays is 
given by (42): 
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 This provides a measure of significance on our calculated correlation or anti-
correlation. The large array sizes typical of our data (N ~10000), give P(r,N) values 
that become negligible very rapidly as a function of r. For example, even for a low 
correlation coefficient of r = 0.1 (N = 10000), we find that P(r,N) ~ 10
–22. This simply   117
reflects the fact that large uncorrelated arrays yield r = 0 with a very narrow 
distribution in r. Hence, the correlation coefficients observed in our data analysis 
prove an underlying correlation, because the probability that they arose from 
uncorrelated data is negligible (typically P(r, N) < 10
–100). 
 
4.3.4.2 Baseline intensity histograms of dip and overshoot regions 
  The baseline intensity histograms of the intrinsic fluorescence underlying the 
dip and overshoot regions are shown in Fig.(4.10). The mean baseline intensity of the 
dip region (mean ± SD: 45±11) is ~22% higher than that of the overshoot region 
(37±8) and ~10% higher than the mean intensity of the entire tissue (41±8).  
 
Figure 4.10 Baseline intensity histograms of dip region (green), overshoot region 
(red) and entire tissue (black). 
 
  It is notable however that while the overshoot region on average has a low 
intensity, overshoot pixels are often found on the somata of astrocytes which actually   118
have a higher intensity than the tissue mean. Nonetheless, most overshoot pixels have 
intensities lower than the tissue mean. Recall however (Section (3.4)), that only the 
astrocyte soma and proximal processes appear bright. The distal processes of 
astrocytes are indistinguishable from the surrounding neuropil. 
 
4.3.4.3 Time evolution of the dip and overshoot regions 
  The intensity responses of those regions that overshoot and dip are different in 
their response magnitude and timing. The dip begins rapidly upon stimulation and 
reaches its maximal response (lowest intensity) in ~10 seconds (Fig.(4.11), red line) 
with a half-time of 2-3s. The dip signal begins to recover immediately upon cessation 
of stimulation. The signal returns to within ~10% of its baseline level in ~30s with a 
~5s half time. In contrast, the overshoot begins slowly and peaks in ~50 seconds 
(green line) with a half time of 20-25s.  
  While the average dip and overshoot magnitude are approximately equal, the 
total area of the overshoot region is ~4 times larger than the total area of the dip 
region. Hence, the integrated response is dominated by the overshoot (black curve), 
and were it not for the temporal offset of these two responses, the dip would not be 
observable in the mean tissue intensity. The dip and overshoot regions do not strictly 
define distinct morphological compartments. Since the two photon focal volume in 
deep tissue (~2µm axial length) is larger than the size of astrocytic processes (<1µm) 
and finer neuronal dendrites, any given pixel can potentially subsume some of both of 
these compartments. The response of a pixel will then depend on whether it is 
predominately astrocyte or dendrite. 
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Figure 4.11 Response of intrinsic fluorescence to stimulation. The integrated 
fluorescence of the entire image (black) exhibits a small dip and a large overshoot. Dip 
and overshoot masks can be applied to dissect the dip (green) and overshoot (red) 
responses. 
 
4.3.5 Discussion of heterogeneous response to activity 
  The high intensity of the dip regions, taken in conjunction with the fact that 
these regions are small and punctuate, suggests that the dip originates from neuronal 
mitochondria. This dip is not likely to arise from astrocytic mitochondria as it is 
almost completely abolished by CNQX, a non-NMDA receptor antagonist which is 
known to not interfere with astrocytic function (3). The effect of CNQX argues that 
the dip is not only neuronal but specifically post-synaptic. In contrast, the low 
intensity of the overshoot regions, as well as their co-localization with 
morphologically obvious astrocytes, reveals that the overshoot arises from astrocytes 
and possibly cytosolic regions of neurons as well.    120
  From the identification of the compartments associated with the dip and 
overshoot, we can interpret the dip/overshoot time course. The initial response to 
tetanic stimulation is a rapid oxidation of NADH in neuronal mitochondria caused by 
an upregulation of the mitochondrial electron transport chain. The recovery of the 
NADH level is then due to an increased Kreb’s cycle activity (NADH source). This 
increased NADH source counteracts the ETC sink of NADH and returns the 
mitochondrial NADH level to approximately baseline levels.  
  The mitochondrial dip was shown to be a dendritic response caused the 
activation of post-synaptic glutamate receptors (3,44). Blockade of these post-synaptic 
glutamate receptors by CNQX was found to almost completely annihilate the dip, with 
a much smaller attenuation of the overshoot.     
 The  astrocytic/cytosolic increase in NADH is much slower and the elevated 
intensity is sustained for a substantial duration after stimulation. This indicates a 
delayed upregulation of astrocytic glycolysis in response to the transient neuronal 
mitochondrial activation. It also implies an increased cytosolic/extracellular lactate 
level (24). The concurrent elevation of extracellular lactate and NADH in response to 
activity has been observed in brain (45) and is thought to be due to lactate secretion by 
astrocytes triggered by glutamate uptake (33,45). Part of this lactate is taken up by 
neurons, converted back into pyruvate and used by neuronal mitochondria to recover 
from the sudden depletion of metabolites due to the activity induced ETC flux 
increase. However the sustained elevation of the astrocytic/cytosolic NADH level 
implies that not all of the lactate produced is committed to oxidative neuronal 
metabolism. This sustained, elevated lactate indicates that some of the glucose used by 
neural tissue is in fact non-oxidatively metabolized by astrocytes.     
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4.3.6 Conclusion 
  This work represents direct evidence in support of the lactate shuttle 
hypothesis (36), integrating previously conflicting views suggested by other functional 
imaging techniques on the oxidative or non-oxidative nature of neuro-metabolic 
coupling (30-32). Our results show the metabolic response of neural tissue has both 
oxidative and non-oxidative components and that these components partition between 
neurons and astrocytes respectively.   122
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Chapter Five 
NADH Conformation and Concentration 
in Tissue 
 
 
5.1 Introduction to intracellular NADH conformation and concentration 
The role of the intrinsic fluorophore β-nicotinamide adenine dinucleotide 
(NADH) as the principal electron donor in glycolytic and oxidative energy metabolism 
makes it a convenient fluorescent probe of metabolic state (1,2). Traditionally, 
fluorimetric studies of metabolic dynamics have characterized metabolic states by the 
total NADH concentration. However, Williamson et al (3) pointed out that the reaction 
velocity of a given intracellular NADH-linked dehydrogenase depends on the 
concentration of locally available NADH i.e., the local concentration of free NADH. 
Given this thermodynamic importance of free NADH, considerable work has been 
done to discriminate the intracellular free fraction of NADH. 
Analytical chemistry techniques have provided the most detailed information 
about intracellular free and total NADH. Pyridine nucleotide extraction (4,5) gives a 
measure of the total tissue NAD
+ and NADH concentrations, while the metabolite 
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indicator method (3,6-8) has been used to infer both the cytoplasmic and 
mitochondrial free NAD+/NADH ratio (9). However, these techniques entail 
destroying the tissue; thereby restricting the study of metabolic dynamics to single 
shot measurements. Furthermore, these techniques are also intrinsically incapable of 
resolving spatial variations in the free/bound state.   
In contrast, fluorescence spectroscopic techniques (10-16) are non-destructive 
and readily extendable to an imaging modality to address spatial heterogeneity. These 
techniques are limited, however, by the ambiguous distinction between free and bound 
NADH fluorescence. Binding induced shifts of the emission spectrum (up to ~20nm) 
(10-12) are small compared to the width of the NADH spectrum (~150nm). 
Fluorescence lifetime is a more sensitive probe of NADH binding as it is enhanced 
significantly (up to 10 times) (13-15). However, the fluorescence decay of bound 
NADH is usually multi-exponential with shorter components that can be comparable 
to the decay time of free NADH (13). This makes it difficult to attribute a fast 
fluorescence decay component in tissue to free or bound NADH. Since intracellular 
NADH exists in dynamic pools of both the free form and bound to many different 
dehydrogenases, the integrated cellular spectra are an uncertain combination of many 
different spectral influences. What is required is a fluorescence signature that can 
unambiguously discriminate between free and bound NADH.  
Here we show that global analysis of time resolved fluorescence and 
anisotropy decays (17,18) provides simultaneous information on the excited state 
dynamics and rotational mobility of intracellular NADH. Binding of NADH leads to 
an exceedingly large (>10 times) increase in the anisotropy decay time  (16), reflecting 
the large difference in the size of the free NADH molecule and the binding enzyme. 
An anisotropy based approach therefore offers the most sensitive discrimination of 
free and enzyme bound NADH. Furthermore, the enhancement in the lifetime of   127
NADH in the intracellular environment provides a measure of the enhancement of its 
fluorescence quantum yield. By correcting for changes in the fluorescence quantum 
yield, we can infer fractional changes in the true NADH concentration as a function of 
metabolic state. We thus present a means of directly monitoring metabolic state 
dependent changes in the total concentration of NADH and its partition into free and 
bound pools, thereby bridging the gap between spectroscopy and analytical chemistry.  
 
5.2 Photophysics of NADH in solution 
5.2.1 Aqueous solution 
  Free aqueous NADH at room temperature exists in two conformations: folded 
(stacked nicotinamide and adenine rings) and extended (no such stacking). We 
measure the total fluorescence decay to be bi-exponential with lifetimes (and 
amplitudes) 350 ps (0.77) and 760 ps (0.23) arising from the extended and folded 
populations respectively (13,19). The resulting average lifetime is 444ps. The 
fluorescence quantum yield of free NADH in buffered aqueous solution is 0.019 (20) 
with an absorption peak at 340nm and an emission peak at 461nm as measured using 
steady state spectroscopy. Using the quantum yield ( f φ ) measured by steady state 
fluorescence and the lifetime (τ ) measured by time resolved fluorescence, it is 
possible to calculate both the radiative rate (kr) and the non-radiative rate (knr) 
(Eqn.(5.1)). 
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The radiative rate, i.e. the rate of spontaneous emission (the Einstein A 
coefficient) is calculated to be 4.75×10
7 s
-1. The non-radiative rate, or the rate at which   128
an excited molecule returns to the ground state without emitting a photon, is calculated 
to be 2.47×10
9 s
-1.  
 
5.2.2 Environmental Effects 
  The photophysical properties of NADH can be affected by any number 
of environmental parameters. We will focus on characterizing the effect of those 
parameters that are known to be variables in the type of in vivo experiments presented 
in this work. The fluorescence quantum yield of a fluorophore can be affected either 
through its radiative rate or through its non-radiative rate. Generally speaking, both 
viscosity and enzyme binding can act on NADH in a similar manner, that is, they 
suppress the vibrational modes of the NADH molecule and therefore reduce 
vibrational quenching of the excited state. This action reduces the non-radiative rate, 
thereby enhancing both the fluorescence lifetime as well as the quantum yield. 
 
5.2.2.1 Viscosity 
Upon increasing viscosity, we find an increase in the integrated fluorescence 
while the absorption remains unaffected. This indicates an increase in the fluorescence 
quantum yield. The increase in quantum yield is also accompanied by a blue shift of 
the emission spectrum (Fig.(5.1A)). 
The average lifetime increases with viscosity (Fig.(5.1B)), due largely to the 
suppression of the non-radiative decay rate. The radiative decay rate is found to 
increase only slightly with viscosity (Fig.(5.1C)). In contrast, the non-radiative rate is 
greatly affected by the viscosity of the solvent (Fig.(5.1D)). The measured relation 
between non-radiative rate and viscosity follows the functional form proposed by 
Wilhelmi (21). 
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Where a = 0 ± 1.5, b = 2.6 ± 1.5 and c = 0.16 ± 0.11.         
 
 
Figure 5.1 Effect of viscosity on NADH photophysics. (A) Emission peak and 
fluorescence enhancement. (B) Average lifetime. (C) Radiative rate. (D) Non-radiative 
rate. 
  It is possible that the non-radiative rate of a fluorophore has a component that 
is not coupled to motion (e.g photoionization). In the case of NADH however, we 
have shown that the functional dependence of the non-radiative rate on viscosity is of 
the form knr = a + bη
-c, where a ~ 0, indicating that the non-radiative decay is largely 
viscosity dependent and hence occurs via motion. 
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5.2.2.2 Enzyme Binding 
  There are seven different cellular dehydrogenases that are known to bind 
NADH in glucose metabolism alone. Each of these enzymes has its own specific 
effect on the NADH steady state and time-resolved properties. We have selected 
lactate dehydrogenase (LDH) and mitochondrial malate dehydrogenase (mMDH) as 
typical examples of these enzymes. Lactate dehydrogenase is a cytosolic enzyme that 
catalyzes the inter-conversion of pyruvate and lactate. Mitochondrial malate 
dehydrogenase is a mitochondrial enzyme that plays a role in the Kreb’s cycle.  
  Complete binding of NADH to mMDH results in a 7nm red shift of the 
absorption spectrum without significant change in its amplitude. The fluorescence 
quantum yield is enhanced by a factor of 1.85 with a blue shift of the emission peak by 
12nm as determined by steady state spectroscopy. Time resolved spectroscopy reveals 
that the lifetime of NADH upon binding is enhanced by a factor of 1.7, somewhat less 
than the enhancement of the quantum yield. This implies that the radiative rate is 
slightly enhanced by a factor of 1.09 (Eqn.(5.1)). In contrast, there is a large decrease 
in the non-radiative rate (factor 0.58). 
  Scott et al (20) have made similar studies of the photophysics of NADH bound 
to lactate dehydrogenase (LDH). Our measurements on mMDH, in combination with 
their results on LDH are summarized in Table (5.1). 
  Enzyme binding can be generally thought of as immersion in a highly viscous 
environment. Due to the tight, specific binding of enzymes to NADH, the fluorophore 
is very rigidly confined and hence the lifetime enhancement of enzyme bound NADH 
can be substantial. Typically the average lifetime of enzyme bound NADH is 2-10 
times greater than that of aqueous NADH, depending upon the enzyme (13,22) and the 
binding of other substrates. In comparison, physiological viscosities produce a 
relatively small lifetime enhancement. Estimates of cellular viscosities vary from 1 to   131
4 times that of water (0.89 mPa s at room temperature) (23,24). From Fig.(6a), we can 
see that such viscosities correspond to an average lifetime enhancement by a factor of 
only ~1-1.3. 
 
Table 5.1 Effect of enzyme binding on NADH photophysics 
Enzyme 
 
Absorption 
peak 
(nm) 
Emission 
Peak 
(nm) 
Quantum 
Yield  Lifetime  Radiative 
Rate 
Non-
radiative 
Rate 
mMDH 347  448  1.85  1.7  1.09  0.58 
LDH 
  335 
440 
(aq. NADH
@ 470nm)
5.2 3.75 1.3  0.24 
 
  While it is true that tight binding suppresses vibrational relaxation of the 
excited state, the binding site of an enzyme can have specific interactions with NADH. 
These specific interactions could entail interaction of the nicotinamide ring with local 
groups in the binding site, or even with the adenine ring of NADH itself. These 
specific interactions can either enhance or reduce the lifetime depending on the 
interaction. At least one enzyme (GPDH: glycerol 3-phosphate dehydrogenase) is 
known to quench NADH fluorescence by 33% (12,25). This quenching is believed to 
be caused by GPDH binding NADH in a conformation in which the nicotinamide and 
adenine rings are stacked. 
  
5.2.2.3 pH 
  The absorption and fluorescence spectra of NADH exhibited no significant 
change between pH 7 and pH 11. This pH range is physiologically relevant as the pH 
in cells varies between ~7-7.5 in the cytoplasm (26) to ~8-8.5 in the mitochondrial   132
matrix (27). The insensitivity of the fluorescence to this pH range is not unexpected. 
The transition between the stacked and extended conformations of the NADH 
molecule is pH dependent with a pK of ~4 (28), far below physiological values of pH. 
Since the relative concentrations of these two photophysically distinct conformations 
do not change in this pH range, therefore neither does the integrated fluorescence of 
the solution.  
 
5.2.2.4 Oxygen quenching 
  While the concentration of intracellular NADH is affected by oxygen level via 
metabolism, the direct quenching of NADH fluorescence by oxygen is also known to 
occur. Czochralska et al (29) measured an oxygen quenching quantum yield (ΦO2) of 
0.02 in the aerobic condition (PO2 ~ 0.2 atm or 152mm Hg) and reported that the rate 
of oxygen quenching fell by a factor of ~4.3 in the anaerobic condition (PO2 ~ 0 (1.5-
3x10
-5 M)). At room PO2, the fluorescence quantum yield (Φf) is 0.02, implying that 
the quantum yield of non-radiative pathways not associated with oxygen (Φnr) must be 
0.96 (1-Φf). 
  Given that the lifetime of NADH at room PO2 is ~400ps, we can calculate the 
radiative rate (kr), oxygen mediated non-radiative rate (kO2) and non-oxygen mediated 
non-radiative rate (knr) as ki = Φi/<τ> summarized in Table (5.1). Under anaerobic 
conditions, kO2 falls by a factor of 4.3 – giving kO2 = 1.15 x 10
7 s
-1. Since the other 
intrinsic rates are not affected (by definition kO2 is the rate affected by oxygen), we 
can now calculate the average lifetime as just <τ> = (kO2 + kf  +  k nr)
-1. This 
calculations yields: <τ> = 406ps, a negligible change in the lifetime due to the direct 
effect of O2 quenching.  
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Table 5.2 Excited state decay rates of aqueous NADH under aerobic conditions 
Aerobic Rates 
kr kO2 knr
5 x 10
7 s
-1 5 x 10
7 s
-1 2.4 x 10
9 s
-1
 
5.2.3 Strickler-Berg calculation of radiative rate 
  In our solution studies, we are able to directly measure fluorescence and 
absorption, and therefore the quantum yield and the fluorescence lifetime. From the 
quantum yield and the lifetime, we can calculate the radiative rate (kr) (Eqn.(5.1)). In 
tissue however, since we cannot easily measure two-photon absorption, we have no 
direct means of measuring the fluorescence quantum yield. Instead, we measure the 
fluorescence lifetime. Traditionally, the radiative rate has been ignored, assuming that 
its value in tissue is not significantly different from its value in solution, or that it 
represents a constant that does not change with metabolic perturbation.  
 It  is possible, however, to use the steady state (wavelength resolved) spectral 
properties of some fluorophores to explicitly calculate their radiative rate from the 
Strickler-Berg relation (30) (Eqn.(5.3)).  
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Here n is the refractive index of the solution,   () F ν and   () ε ν  are the fluorescence and 
absorption spectra respectively as a function of the wavenumber  ν . For free, aqueous 
NADH, we find that the radiative rate calculated using the measured quantum yield 
and lifetime (kr(φ,τ)) is 4.75×10
7 s
-1. In comparison, the radiative rate calculated from   134
the Strickler-Berg relation using the measured wavelength resolved spectra (kr(n,F,ε)) 
is 4.74×10
7 s
-1. This excellent agreement suggests the possibility of using the 
wavelength resolved spectral properties of intrinsic NADH to probe its radiative rate.  
  Shifts in the fluorescence emission peak in response to environmental effects 
(e.g. enzyme binding) can be significant (up to 30nm (12)) and therefore contribute a 
significant change to the radiative rate. Figure (5.2) shows the calculated change in the 
radiative rate caused by the simulated shift of the emission peak assuming the 
refractive index and absorption spectrum remain constant.  
 
 
Figure 5.2 Calculated change in the radiative rate due to simulated fluorescence 
spectral shift. 
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  In contrast, shifts in the 340nm absorption peak of NADH are small – rarely 
exceeding 10nm (12). A simulated shift of the 340nm absorption band contributes 
little to change to the radiative rate (Fig.(5.3)). Shifts characteristic of enzyme binding 
(<±10nm) contribute a <±3% change in the value of the absorption integral term in 
Eqn.(5.3). It is therefore not necessary to consider shifts in the absorption spectrum to 
get a reasonable approximation of the radiative rate. 
 
Figure 5.3 Calculated change in radiative rate due to simulated absorption shift. 
  To check the validity of applying the Strickler-Berg relation to NADH in a 
more complex environment, we compare the radiative rate calculated from the 
quantum yield and lifetime to that obtained from the Strickler-Berg relation in a 
viscous environment and bound to an enzyme.  
  A viscous environment has no effect on the 340nm absorption band, while it 
blue shifts and enhances the fluorescence in a well-defined way (see above). The blue   136
shift of the fluorescence increases the fluorescence integral term in Eqn.(5.3). 
Furthermore, the refractive index of the glycerol/water solvent mixture was taken from 
standard tables (31). Taking the changes in the fluorescence spectrum and the 
refractive index of the solvent into account in Eqn.(5.3) gave an excellent agreement 
(within 5%) between the radiative rates calculated by the Strickler-Berg relation and 
by the quantum yield/lifetime method. This agreement held for a wide range of 
physiologically relevant viscosities (<10 mPa s) (Fig. (5.4)), indicating that the 
Strickler-Berg model is a good approximation for free NADH in a viscous 
environment.  
 
Figure 5.4 Strickler-Berg relation predicts the radiative rate of free NADH in a 
viscous environment. 
 
  Complete binding of NADH to mitochondrial malate dehydrogenase (mMDH) 
results in a 7nm red shift of the absorption spectrum without significant change in its 
amplitude. The blue shift in the emission spectrum increases the fluorescence integral 
term in Eqn.(5.3) by a factor of 1.08. The red shift of the absorption spectrum 
decreases the absorption integral term by a factor of 0.98. Therefore, the net change in   137
the radiative rate as calculated by a Strickler-Berg analysis of the steady state spectra 
is a factor of 1.06 – reasonably close to the enhancement of 1.09 calculated from the 
quantum yield and lifetime.  
  Scott et al (20) have made similar studies of the photophysics of NADH bound 
to lactate dehydrogenase (LDH) and have also found that the radiative rates calculated 
from the Strickler-Berg relation and the quantum yield/lifetime are in good agreement. 
Thus, in the cases of at least these two typical NADH binding enzymes and free 
NADH in a viscous environment, the wavelength resolved spectral properties of 
NADH appear to provide a good approximation of the radiative rate.  
  We have assumed here that the refractive index does not change during 
enzyme binding if the surrounding medium is aqueous buffer. However, the local 
environment of an enzyme bound fluorophore – which consists of the binding site of 
the enzyme as well as the solution surrounding the enzyme itself – can affect the 
radiative properties of the fluorophore. Toptygin et al (32) have shown that the 
radiative rate of tryptophan residues within an enzyme are affected by the local 
environment within the enzyme as well as the solution around the enzyme. In effect, 
the fluorophore is sensitive to any variations of the refractive index within several 
wavelengths of the fluorophore even if the length scale of those variations are sub-
wavelength. As such, the variation of the refractive index on a microscopic scale in 
tissue remains an uncertainty in this work. 
 
5.3 Fluorescence anisotropy and lifetime in tissue 
5.3.1 Tissue fluorescence measurement 
  Time resolved fluorescence decays were recorded from the stratum radiatum 
(SR) of the CA1 layer of rat hippocampal slices. Each slice was subjected to a 10 
minute hypoxic episode during which the intrinsic fluorescence increased in intensity   138
by an average of 48±26%. Reperfusion with oxygenated solution returned the 
integrated fluorescence to approximately baseline levels as expected (see Section 3.2.2 
and 4.2), indicating negligible photodamage. The intrinsic fluorescence from the 
hippocampal slice consists of both a blue NADH peak and a yellow flavin peak that 
respond differently to hypoxia (see Section 3.3). However our choice of emission filter 
ensured the contribution from the NADH peak to the detected fluorescence was 
greater than 95%.  
  Fluorescence decays at parallel and perpendicular polarizations were measured 
sequentially and used to calculate the total (magic angle) fluorescence decay and the 
anisotropy decay. Each total fluorescence and anisotropy decay pair was fit 
simultaneously using a global analysis to obtain the parameters characterizing both the 
excited state lifetime and the rotational mobility.  
 
5.3.1.1 Fluorescence decay functional form 
  Functional forms used in fitting fluorescence decays and measures of goodness 
of fit have been discussed in Section (2.4). A case study of a typical fit is presented 
here to justify the functional form that we have used to fit tissue fluorescence decay. 
The tissue fluorescence decay parameters are summarized in Figure (5.5).  
  It was found that fitting with 1 or 2 exponential decay components generated 
very large χ
2 and will not be discussed further. Hence, at least 3 exponential decay 
components were required. Furthermore, including a scatter term in the functional 
form resulted in a decrease in χ
2 by more than a factor of 2. The inclusion of a 
scattered light term is physically reasonable as tissue tends to be highly scattering. 
Since the two-photon action cross section of intrinsic fluorescence is extremely low, a 
relatively high power (O(10mW)) must be sent into the tissue to achieve a detectable 
fluorescence signal. Even if only a small fraction (~1%) of this red excitation light is   139
backscattered, and largely extinguished by the emission filters (~1%), this still leads to 
a significant signal (O(1µW)) reaching the detector. Given the single photon 
sensitivity of the lifetime detector, this can translate into a significant scatter signal. 
 
 
Figure 5.5 Case study - number of components required for tissue fluorescence 
decay fit. 
 
  We are left to consider whether 3 or 4 exponential decay components are 
sufficient. Figure (5.5) shows the fit parameters, χ
2, residuals and the autocorrelation 
of residuals of the fits using 3 exponential decay components (n=3) versus those using 
4 (n=4) exponential decay components. Both fit functions have scatter components. 
Relying solely upon χ
2 as the criterion for goodness of fit, one might conclude that 3 
components is an adequate as it gives a low χ
2 (1.2) which improves by only 0.1 upon 
adding another decay component. However, if we examine the residuals and their   140
autocorrelations, we find that the n=3 fit residual has a non-random structure which is 
evidenced by its autocorrelation. The n=4 fit yields residuals and their auto-correlation 
that are randomly distributed about zero. Hence, the appropriate fitting model for 
tissue total fluorescence decay has 4 exponential decay components and a scatter term.   
 
5.3.1.2 Average fluorescence decay fit parameters 
  The average of the total fluorescence decays (n=6) under both normoxic and 
hypoxic conditions are shown in Fig.5.6. The tissue fluorescence is found to have four 
exponential decay components (we will call these species 1 through 4) whose 
lifetimes(τi) and amplitudes (ai), are summarized in Table (5.3). 
 
 
Figure 5.6 Intrinsic fluorescence decays. Intrinsic fluorescence decays are sensitive 
to metabolic state. The lifetime is reduced from the normoxic (blue) state to the 
hypoxic (red) state.   141
  The lifetimes (τi) are characteristic decay times of the excited state of each 
species. The amplitudes (ai) of the species are the relative concentrations of the 
species. In response to hypoxia, there is a modest decrease in all but the longest time 
constant. The amplitudes however are heterogeneous in their response. There are 
decreases in the amplitudes of the two longer lifetime species in favor of the two 
shorter lifetime species. The net effect of these changes is a decrease in the average 
lifetime from 948±46ps (normoxia) to 780±17ps (hypoxia).   
 
Table 5.3 Mean (SEM) fit parameters for intrinsic fluorescence decays 
 
  From the total fluorescence decay parameters, we can calculate a number of 
physically important quantities. Firstly, the changes in the absolute concentrations of 
the individual species (∆Ci) are calculated to be: 86±45% (species 1), 104±43% 
(species 2), 39±25% (species 3) and 58±35% (species 4). The increase in the total 
concentration of NADH upon hypoxia was calculated to be 81±39%, which is 
substantially greater than the change in the total fluorescence (48±26%) due to the 
decrease in the fluorescence average lifetime. The large errors are due to significant 
variation in the integrated fluorescence response to hypoxia and not to large errors in 
the fitting parameters. Secondly, the fractional contributions to the fluorescence (fi) 
from each species during normoxia can be calculated to be: 7% (species1), 20%   142
(species 2), 46% (species 3) and 27% (species 4). Note that while species 1 has the 
largest concentration (44%), it contributes the least to the total fluorescence due to its 
short lifetime.  
  The total fluorescence decay exhibits a spike at t0 due to backscattered excitation 
light from the tissue that increased by 47±20% upon hypoxia. This increase in scattered 
light has been observed during sustained hypoxia and although its cause is not fully 
understood, is possibly due to mitochondrial swelling (33-35). 
Figure 5.7 Anisotropy decays of intrinsic fluorescence. Both normoxic (blue) and 
hypoxic (red) decays exhibit the functional form of associated anisotropy – indicating 
multiple conformations of NADH. 
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  To further characterize the fluorescent species, we calculated the rotational 
anisotropy decays from the intrinsic tissue parallel and perpendicular fluorescence 
components. Typical anisotropy decays (Fig.(5.7)) exhibit a rapid initial decay, 
followed by a rise and then a second slower decay. This form is characteristic of 
fluorescence anisotropy arising from a mixture of fluorophore species with each 
species having its own distinct fluorescence decay and fluorescence anisotropy decay, 
and is known as associated anisotropy (36,37).  
 
Table 5.4 Mean (SEM) anisotropy decay fit parameters. 
 
  By utilizing the associated anisotropy model in our fitting protocol we 
determined the rotational diffusion time and initial anisotropy of each species of the 
total fluorescence decay and thereby characterize the conformations of NADH as a 
function of metabolic state. The anisotropy parameters (r0i,θi) obtained by the fit are 
summarized in Table (5.4). Of particular note, the shortest lifetime species (species 1) 
has a fast rotational diffusion time of 318±101ps during normoxia that decreases upon 
hypoxia to 230±58ps. In contrast, all three longer lifetime species are essentially 
immobile, with large rotational diffusion times that are insensitive to the tissue 
metabolic state. The two-photon initial anisotropies of all the species are also 
insensitive to metabolic state, excepting species 2 which exhibits a significant   144
decrease of the initial anisotropy from 0.33±0.01 to 0.25±0.02, indicating an increased 
mode of depolarization faster than our time resolution. 
 
5.3.2 Comparative measurements of NADH in solution 
  The photophysical properties of the intracellular fluorescence species can be 
used to physically identify them by comparatively considering the photophysical 
characteristics of NADH in solution. Free aqueous NADH at room temperature exists 
in two conformations: folded (stacked nicotinamide and adenine rings) and extended 
(no such stacking). We measure the total fluorescence decay to be bi-exponential with 
lifetimes (and amplitudes) 350 ps (0.77) and 760 ps (0.23) giving an average lifetime 
of 444 ps. The two lifetime components are comparable to those reported in literature 
and are believed to arise from the extended and folded populations respectively 
(13,19). The fluorescence anisotropy decay was found to be mono-exponential, with a 
rotational diffusion time of 290 ps and an initial anisotropy of 0.38 (Fig.(5.8), blue 
curve). The rotational dynamics reported here are consistent with those reported by 
Couprie et al (19) who further showed that  the NADH rotational diffusion time 
exhibits a Stokes-Einstein dependence on viscosity and temperature (Eqn.(2.17)). 
Based on the Stokes-Einstein dependence measured by Couprie et al, we expect a 
reduced rotational diffusion time for free aqueous NADH of ~150 ps at the 
temperature of tissue in our experiments (~32°C). 
  NADH fluorescence and anisotropy are sensitive to enzyme binding. As an 
example, we titrate the large NADH-binding Krebs’ cycle enzyme mitochondrial 
malate dehydrogenase (mMDH, MW=70kD) against NADH (MW=665). At a 
sufficiently high concentration of mMDH ([NADH binding sites]/[NADH] = 4), all 
available NADH is bound. In this case, the fluorescence decay is bi-exponential with 
components 602 ps (0.72) and 1.33 ns (0.28) yielding an average lifetime of 806 ps.   145
The anisotropy decays as a mono-exponential with an initial anisotropy of 0.49 and a 
rotational diffusion time of 30 ns (Fig.(5.8), red curve). The long, single exponential 
anisotropy decay implies that the NADH fluorophore is rigidly bound without 
significant segmental mobility within the much larger enzyme.   
 
Figure 5.8 Anisotropy of free and bound NADH. Anisotropy of NADH free (blue) 
and fully bound to mMDH (red) are mono-exponential while a mixture of free and 
bound species (green) displays associated anisotropy. 
 
  At a non-saturating concentration of mMDH ([NADH binding sites]/[NADH] 
= 0.2), there is a mixture of free and bound NADH yielding a fluorescence anisotropy 
decay with the form of associated anisotropy (Fig.(5.8), green curve). The anisotropy 
of this mixture was fit by setting the rotational and lifetime decay parameter values 
(Eqns. 12, 13) constant at the values for fully free and fully bound NADH measured   146
above. The relative population of free and bound NADH ([NADH]/[NADH·mMDH]) 
was however taken as a floating parameter and determined by the global fit to be 1.0. 
The accuracy of the global fit determination of free/bound NADH was checked by 
independently estimating the free/bound ratio using the average lifetime of the mixture 
( free free bound bound mixture aa τ ττ <> + < > = < > ,  1 free bound aa + = ; data not shown). This 
method gave a free/bound NADH ratio of 0.9 – in reasonable agreement with the 
value obtained from the global fit. The strong resemblance of the anisotropy decay of 
the bound-free mixture to that observed in tissue is indicative of coexistent free and 
bound NADH in tissue. This further validates the use of global lifetime and associated 
anisotropy fitting to discriminate and characterize intracellular free and bound NADH. 
 
5.3.3 Identification of intracellular free and enzyme bound NADH 
  Comparing the lifetime and rotational anisotropy characteristics of NADH in 
vitro to our results in tissue enables us to identify the observed fluorescent species of 
intracellular NADH. This identification and the behavior of the species upon hypoxia 
are summarized in Table (5.5).  
 
Table 5.5 Summary of intrinsic NADH conformation identification 
 
  The short lifetime species (species 1) has a relatively fast rotational diffusion 
time somewhat greater than that of aqueous NADH (150ps) at tissue temperature. This   147
high rotational mobility is consistent with this species being free NADH in a slightly 
viscous environment. The lifetime of species 1 is comparable to the lifetime of free 
extended NADH but substantially shorter than the lifetime of free folded NADH. 
Taken together, the lifetime and anisotropy parameters for species 1 suggest that it is 
free extended NADH in a slightly viscous environment. 
  Species 2 has a lifetime that is consistent with being either folded NADH, or 
enzyme bound NADH. Its rotational diffusion time however (~8ns) is almost two 
orders of magnitude greater than that of free NADH, indicating that this species is also 
bound NADH. This species undergoes a significant decrease in its initial anisotropy 
(0.33 to 0.25) upon hypoxia, indicating an enhanced mode of fast depolarization, e.g. a 
fast segmental motion of the nicotinamide ring within an enzyme, or a specific 
interaction in the binding sites which increases the angle between the nicotinamide 
absorption and emission dipoles. While the cause is uncertain, we can still identify this 
species as enzyme bound from its diffusion time. The two longest lifetime species 
(species 3 and 4) are rotationally immobile on the timescale of our measurement 
window (~10ns) and their lifetimes are much greater than the lifetimes of either folded 
or extended aqueous NADH. Both the highly enhanced lifetime and rotational 
immobility suggest that these two species are NADH bound to enzymes. The 
identification of species 2, 3 and 4 as enzyme bound does not imply that there are only 
three different enzymes binding NADH. In reality there are known to be many 
different enzymes binding NADH, and their net fluorescence is observed as 
components 2, 3 and 4. 
  It is noteworthy that we do not observe the expected ~600ps fluorescence 
decay component of free folded NADH in brain slices. However, it is difficult to say 
whether this reflects an inability to separately resolve its decay, or a genuinely small 
intracellular concentration of free folded NADH.    148
  From the identification of these species, the relative concentration of free 
NADH is given by the amplitude of species 1 (afree=a1) while the relative total 
concentration of bound NADH is given by the sum of the amplitudes of the 3 bound 
species (abound=a2 + a3 + a4). The ratio of the free/bound NADH (afree/abound) can then 
be calculated to be 0.78±0.05 during normoxia and remains essentially unchanged 
upon hypoxia. Even though hypoxia does not affect the ratio of free NADH to the total 
concentration of bound NADH, it does affect the relative populations of the three 
enzyme bound species (Table (5.3)), indicating a redistribution of NADH among 
different enzymes. Hence while the free NADH concentration appears to remain 
approximately equal to the total concentration of bound NADH, its distribution 
amongst various bound species changes with its chemical potential – indicating a 
range of binding constants and cofactor concentrations in the intracellular 
environment. 
 
5.3.4 Calculating the local intracellular viscosity 
  Having identified species 1 as free NADH, we can use its rotational diffusion 
time with the Stokes-Einstein relation for free NADH measured by Couprie et al (19) 
to calculate the local intracellular viscosity. In this way, the local viscosity 
experienced by free intracellular NADH is calculated to be 1.6±0.5mPa s (2.1±0.7 
relative to water at 32°C) during normoxia and decreases upon hypoxia to 1.1±0.3mPa 
s (1.5±0.4 relative to water at 32°C).  
 
5.3.5 Discussion of intracellular conformation and environment 
  Enzyme binding of NADH has been characterized by a number of fluorescence 
techniques that are differently sensitive to binding. The weakest effect is the shift of 
the NADH emission peak upon binding which is typically less than 10% (∆λ/λ < 0.1).   149
The lifetime of NADH is more sensitive to enzyme binding and can be enhanced by a 
factor of ∆τ/τ ~ 1-10. Fluorescence anisotropy offers an even greater sensitivity to 
enzyme binding due to the large difference in size between NADH (MW=665) and the 
enzymes that tightly bind it, e.g. mitochondrial malate dehydrogenase has a molecular 
weight of 70kD. Enzyme binding increases the rotational diffusion time of NADH by 
more than an order of magnitude (∆θ/θ ~ 10-100), rendering the fluorophore 
effectively immobile on our time scale of measurement. Hence, measuring the 
rotationally mobile versus immobile intracellular NADH offers the most sensitive 
fluorescence probe of the free versus bound conformation. 
  Based on our measurements of rotational anisotropy, we conclude that 
intracellular NADH exists in both free and bound forms in comparable concentrations 
(free/bound = 0.78). However, it is the bound NADH that dominates (93%) the total 
tissue fluorescence due to its substantially enhanced lifetime. This dominance of the 
bound NADH fluorescence has lead analyses of the wavelength resolved tissue 
fluorescence spectra to prematurely conclude that tissue NADH is almost completely 
enzyme bound (10). In contrast, our results indicate that free NADH is in fact 
significant in concentration if not in fluorescence. 
  The ratio of free NADH to individual enzyme bound species of NADH is 
found to change significantly upon hypoxia, while the ratio of free NADH to total 
bound NADH does not. This indicates a redistribution of NADH amongst enzyme 
binding sites. Specifically, there is a large increase in the concentration of free NADH 
and the concentration of NADH bound to enzymes that cause low lifetime 
enhancement. The concentration of NADH bound to those enzymes causing large 
lifetime enhancement increases to a lesser extent. The net effect of this redistribution 
of NADH among binding sites is a decrease in the average lifetime of the intrinsic 
fluorescence, causing the observed fluorescence increase (48%) to underestimate the   150
calculated concentration increase (81%). Since the ratio of free to bound NADH does 
not change upon hypoxia, this calculated concentration increase applies to both free 
and bound pools of NADH. 
  In comparison, assays of chemically extracted NADH from cerebral cortical 
brain slices showed that the total NADH concentration increased by 107% upon acute 
hypoxia (5). Metabolite indicator methods reveal a 105% increase in the free 
mitochondrial NADH (8) in brain upon hypoxia. These concentration increases are 
clearly much closer to our calculated concentration increase than to our observed 
fluorescence increase. However, a strict comparison should not be drawn between our 
results and the results of the metabolic indicator method as NADH increases are 
dependent upon the degree of hypoxia as well as the region of the brain, both of which 
may differ from our experiments.  
  In relating fluorescence changes to concentration changes, we have assumed 
that changes in the quantum yield are proportional to changes in the lifetime. This is 
only strictly true if the radiative rate remains constant (Eqn.(5.1)). The radiative rate 
depends on the overlap of excited and ground states, which can be expressed as a 
function of the fluorescence and absorption spectral lineshapes (shape of the 
normalized spectra) as expressed by the Strickler-Berg relation (30). We find that the 
lineshape of the NADH portion of the intrinsic fluorescence changes only slightly 
upon hypoxia (Fig.(3.12)) - suggesting that the average radiative rate of intracellular 
NADH is not significantly altered. However this is not conclusive as we do not know 
the behavior of the absorption spectral lineshape.  
  The rotational dynamics of intracellular free NADH indicate a relatively low 
viscosity (~1.6mPa s). This is not unexpected as fast rotational diffusion and 
conformational changes take place on length scales that are short and therefore 
sensitive to only the immediate fluid phase viscosity and molecular crowding (together   151
known as the effective viscosity) (38). Local fluid phase viscosities comparable to that 
of water have been observed in a number of cells and sub-cellular compartments, 
including mitochondria (23,24,38,39).  
  The decrease in the intracellular viscosity upon hypoxia (to 1.1mPa s) possibly 
reflects a dilution of the intracellular environment caused by the osmotic swelling of 
the cell soma and mitochondria. Sustained hypoxia is known to induce osmotic cell 
swelling and an increase in scattered light (33-35). The cause of this increase in 
scattered light is unknown, however it has been suggested that it is due to 
mitochondrial swelling (33) in response to hypoxia induced spreading depression. It is 
thought that mitochondrial swelling increases the cross-section of scatterers and 
therefore the scattering signal, assuming that there is a significant difference between 
the refractive index of mitocondria and of the cytosol. Given that we also observe an 
increase in scattered light upon hypoxia, it is plausible that compartmental swelling 
and the resulting dilution is reducing the intracellular viscosity. 
  As we have seen, the response of NADH to hypoxic metabolic inhibition is 
more complicated than a simple concentration increase. Changes occur in not only the 
concentration, but also in the conformation and the environment of intracellular 
NADH. We have presented here a means to discriminate and monitor these effects, 
enabling a more precise measurement of the dynamics of the actual intracellular 
NADH concentration and its partition into free and bound pools.  
 
5.4 Regional variations of intrinsic NADH photophysics  
  Imaging experiments have shown that the magnitude of the fluorescence 
response to hypoxia is region specific. In particular, the fluorescence increase in the 
dendritic layer (stratum radiatum; SR) is 2-3 times greater than the increase in the cell 
soma layer (stratum pyramidale; SP). The variation of metabolic response reflects   152
differences in mitochondrial populations between different regions. This difference in 
the mitochondrial population also entails a different average environment for NADH 
in these regions. In order to characterize the differences in the photophysical 
properties of NADH in these different regions, we measured the time resolved 
intrinsic fluorescence in the CA1 SR and SP. 
  The time-averaged intrinsic fluorescence of the SR increased by 37 ± 11% in 
response to hypoxia. The average excited state fluorescence lifetime (1.2 ± 0.2 ns) is 
reduced (1.01 ± 0.09 ns) upon hypoxia.The response of the SP (cell layer) to hypoxia 
is qualitatively similar to that of the SR, with relatively minor differences. The 
magnitude of the response to changing metabolic state was generally lower. The 
integrated fluorescence increased by 17±7%. The average lifetime decreased upon 
hypoxia from 1.03±0.08ns to 0.91±0.07ns. The average decays from both regions and 
under both normoxia and hypoxia are shown in Fig.(5.9). The most obvious difference 
between the two regions is that the SP fluorescence is only slight affected by 
metabolic state while the SR effect is more substantial.  
  These experiments measured gross spatial variation in the decay characteristics 
of NADH fluorescence with respect to two morphologically different regions of the 
hippocampal CA1 layer. However, in order to accurately measure the scale of these 
spatial variations, it is necessary to use an imaging modality. Future experiments will 
employ fluorescence lifetime imaging to measure spatial variations within the 
hippocampus with cellular and sub-cellular resolution. 
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Figure 5.9 Lifetimes and hypoxic responses of different hippocampal regions. 
 
5.5 Concentration calibration of intracellular NADH 
  In order to measure absolute concentration of NADH in the hippocampus, we 
compared fluorescence images of slices using two-photon laser scanning microscopy 
to the fluorescence of aqueous NADH solutions of known concentrations imaged 
under identical conditions. The solution fluorescence provides a calibration of 
fluorescence as a function of NADH concentration that is not yet corrected for light 
attenuation and the enhancement of the fluorescence quantum yield in tissue.  
  Correction for light attenuation: The decrease of the NADH fluorescence 
signal with depth is a function of light attenuation on one hand and the increase in the 
NADH concentration as a function of decreasing tissue oxygen on the other. However, 
NADH does not increase significantly until the local PO2 falls to less than 0.1 atm. For 
a normoxic perfusate PO2 (>0.6 atm), the oxygen level in tissue does not fall to this   154
level until a depth of >60µm (see Section (2.6)). Hence the attenuation of the NADH 
signal in the superficial 60µm of a brain slice is due only to light attenuation.  
  The depth attenuation of the NADH fluorescence down to a depth of 60µm can 
be fit to an exponential decay (Fig.(5.10a)), with deviation occurring in the first 10-
20µm due to superficial cell death as a consequence of slice preparation. Having 
characterized the fluorescence attenuation, we can correct for this factor in images 
taken in deeper, healthy tissue (below 30µm).  
 
Figure 5.10 Calibrating intrinsic NADH fluorescence to concentration. Calibrating 
NADH fluorescence requires first characterizing the fluorescence attenuation (A) and 
then relating fluorescence and concentration (B) using standard solutions of NADH.  
 
  The attenuation corrected tissue fluorescence can then be compared to the 
fluorescence of aqueous NADH standards of known concentrations (Fig.(5.10b)) to 
provide a first estimate map of tissue NADH concentration. This first estimate 
(Fig.5.11) needs to be further corrected for the enhanced quantum yield of intrinsic 
NADH.       155
 
Figure 5.11 Map of NADH concentration - before correcting for quantum yield. 
Scale bar is 20µm. 
 
  The enhancement of the quantum yield is simply the product of the 
enhancement of the radiative rate and the enhancement of the lifetime as measured by 
steady state and time resolved spectroscopy respectively. The measurement of these 
enhancement factors for both SR and SP have been discussed in previous sections and 
are summarized in Table (5.6). The fluorescence lineshape, and therefore the radiative 
rate, does not change significantly upon hypoxia. Since there is no way to measure the 
two-photon absorption spectrum in tissue, the contribution of the absorption integral   156
term to the radiative rate cannot be calculated here. However, as discussed above, the 
contribution of the absorption shift to a change in the radiative rate is small (<~3%) 
and can be neglected.  
 
Table 5.6 Correction factors for estimating intrinsic NADH concentration. 
 
 
  Under normoxic conditions, the uncorrected average concentration in the SR is 
calculated to be ~390µM and that in the SP is ~250µM. Taking into account the 
enhancement of the quantum yields, the corrected average concentration in the SR is 
119µM while that in the SP is 92µM. Upon hypoxia, the total NADH concentration 
increases by 64% (to 195µM) in the SR and by 25% (to 115µM) in the SP. In contrast, 
the NADH fluorescence (uncorrected concentration) increases by only 37% in the SR 
and 13% in the SP. Hence we see already a significant error in the measure of 
concentration and concentration changes if the quantum yield is not monitored. 
  Analytical chemistry measurements of the NADH content in rodent brain 
tissue extracts typically fall in the range of ~57-128 uM (4,40,41). In particular 
Klaidman et al (4) used HPLC to determine the concentration of NADH in the mouse   157
hippocampus to be 0.057±0.018 umol/g of brain tissue and the total NADH and 
NAD+ concentration to be 0.253±0.037umol/g brain tissue. These measurements 
correspond to an average intracellular NADH molar concentration of ~57uM and a 
combined NADH and NAD+ concentration of ~253uM, assuming the density of brain 
tissue to be roughly that of water.  
  The total concentration of NADH and NAD+ measured by these techniques is 
particularly important as it represents the maximal concentration that NADH can have 
in the tissue under the condition of complete reduction of the redox pair. This total 
concentration of NADH and NAD+ does not depend upon the specific metabolic state 
of the tissue nor is it sensitive to artefactual oxidation of NADH during sample 
preparation – which can be a problem in these types of measurements (4). The NADH 
level alone however is not a constant, but rather a variable that depends on the 
metabolic state.  
  While analytical chemistry (HPLC) has been able to measure NADH 
concentrations in gross tissue samples, these techniques entail destroying the tissue 
and are have the potential for artefactual oxidation of NADH during preparation. Two 
photon time resolved fluorescence measurement offers a probe of intracellular NADH 
excited state dynamics that is non-invasive and causes minimal photodamage, 
enabling prolonged data acquisition from a single living hippocampal slices in a 
controlled metabolic state.  
 
5.6 Optical properties of brain slices 
5.6.1 Absorption 
  Fluorescent chromophores intrinsic to biological tissue have been discussed 
earlier in Section (3.1). Besides these, there are also chromophores that absorb without 
fluorescence. Tissue absorbers that are metabolically inert (e.g. melanin) represent a   158
constant attenuation of excitation and emission light. However, tissue absorption 
spectra from 510 to 620nm contain distinct peaks that reflect the oxidation states of 
the several cytochromes in the electron transport chain (42) and therefore the 
metabolic state of the cell. Given the wavelength of these peaks, neither the two-
photon excitation (730-740nm) nor emission (400-550nm) of NADH fluorescence 
overlaps significantly with these absorption peaks and are therefore not sensitive to 
cytochrome oxidation states - beyond the direct biochemical coupling of NADH 
concentration to metabolic state.   
  Jobsis (43) first demonstrated that near infrared spectroscopy can be used to 
monitor oxygen consumption in brain tissue by resolving spectral contributions of 
cytochrome oxidase (CytOx), hemoglobin (Hb) and oxygenated hemoglobin (HbO2) 
to absorption in the 700-1000nm wavelength range. In brain slices, the differential 
absorption of Hb and HbO2 is irrelevant as the brain slice is largely exsanguinated and 
receives oxygen directly from the perfusion medium. The absorption of light due to 
CytOx is dependent upon its oxidation state. The difference between oxidized and 
reduced CytOx specific extinction coefficient is ∆ε ~ 0.002 µM
-1cm
-1 at 700-750nm 
(44). At path length scales relevant to functional imaging in brain slices (~100µm) and 
cytochrome oxidase concentrations typical of 2-3 week old rat brain (~3µM)(45), this 
difference in extinction is ∆ε ~ 6x10
-5. Assuming a maximal change in the CytOx 
oxidation state, the resulting fractional change in the attenuation of the red excitation 
beam reaching the focal plane isexp( ) 0.99994 ε −∆= . This is a negligible change, and 
hence we can ignore absorption changes due to the cytochrome oxidase oxidation 
state.   
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5.6.2 Scattering 
  Scattering due to morphological changes is monitored >620nm as absorption 
changes in this region are small. Chance et al (1963) (46) measured the reflectance 
change at 700-710nm to be negligible upon anoxia in rat cortex. There were scattering 
changes in the 400-550nm region of NADH emission, however scattering changes of 
emission should not substantially affect the efficiency of collection as, on average, just 
as many photons scatter into our collection optics as scatter out of them. 
  Scattering changes are affected by the cellular and sub-cellular morphology of 
brain slices. Changes in morphology in turn depend upon the nature of the 
physiological perturbation of the brain tissue. These perturbations are usually via: 
1. Osmolarity 
2. Excitation 
  a. Sustained tetanic stimulation 
  b. Bulk depolarization (by K
+ or NMDA injection) 
3. Hypoxia 
  a. Brief hypoxia without spreading depression 
  b. Sustained hypoxia with spreading depression 
Depending upon the specific perturbation, the morphological changes can include 
cellular swelling/shrinkage, mitochondrial swelling/shrinkage, and dendritic beading. 
  During sustained hypoxia (~10 min), Bahar et al (34) found that a 
depolarization of the mitochondrial membrane (indicated by rhodamine 123 
fluorescence increase) was accompanied by a biphasic response of the transmittance 
(at ~650nm) – an initial brief and small increase followed by a large sustained 
decrease. Measurements of interstitial volume and transmittance/scattering during 
osmotic perturbations have shown that cellular swelling is associated with increased 
transmittance (reduced scattering) (47,48)). Cellular swelling is known to occur during   160
hypoxia (49,50) and hence one might expect a reduction in scattering upon hypoxia, 
however the opposite has been observed. While the mechanism of this hypoxia 
induced scattering increase is not fully understood, it is known to occur with hypoxic 
spreading depression. Muller & Somjen (33) have suggested mitochondrial swelling as 
a possible cause assuming that the mitochondrial refractive index is sufficiently 
different from that of the cytoplasm. The bi-phasic response of the transmittance 
observed by Bahar et al could then be interpreted as a superposition of two different 
effects – cellular swelling induced scattering decrease and mitochondrial swelling 
induced scattering increase (35). 
 
5.7 Conclusions 
  Metabolic perturbations to neural tissue have a wide range of effects that can 
influence the intrinsic NADH fluorescence. Unless these effects are accounted for, we 
cannot interpret changes in NADH fluorescence as strictly representing changes in 
NADH concentration. Among these effects, we have found that the binding state and 
local viscosity of intracellular NADH are sensitive to metabolic state. The net effect of 
the conformation and environmental changes on the lifetime of intracellular NADH 
causes the fluorescence change upon hypoxia to significantly underestimate the 
concentration change. We have used fluorescence lifetime and rotational anisotropy to 
measure these effects and thereby correct for them. The resulting calculation of 
NADH concentration change in response to hypoxia is in good agreement with 
analytical chemistry measurements and has the added advantage of being non-
destructive.  
  It is a logical next step to apply this time resolved fluorescence-anisotropy 
probe to an imaging modality to explore the spatial heterogeneity of the NADH   161
concentration and conformation – both on an inter-cellular (e.g. neurons vs. 
astrocytes) and sub-cellular compartment level. 
  Furthermore, throughout this work, we have assumed that the local refractive 
index of intracellular NADH is unchanged. We have also assumed that the NADH 
two-photon absorption cross section experiences no significant change in amplitude or 
wavelength in tissue. Future work needs to clarify how these parameters are affected 
for intracellular NADH.  
  NADH fluorescence has seen a resurgence in its use as an intrinsic probe of a 
wide range of interesting cellular and tissue phenomena, ranging from neuro-
metabolic coupling (51) to nuclear transcription regulation (52), to enzyme kinetics 
within intact cells (53). The fluorescence based assay of NADH concentration and 
conformation presented here will enhance our ability to precisely quantify the role of 
NADH in these phenomena and develop an accurate picture of NADH biochemistry in 
vivo.  162
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